Embed Size (px)
Citation preview
Curriculum Vitae
Mark S. Slaughter, M.D.
Principle Address:
Department of Cardiovascular and Thoracic Surgery
201 Abraham Flexner Way, Suite 1200
Louisville, KY 40202
P: 502.588-7600
F: 502.588-7701
Current Appointments:
Professor of Surgery
Chairman
Department of Cardiovascular and Thoracic Surgery
University of Louisville
Louisville, KY 40202
Executive Medical Director
Cardiovascular Services
Jewish Hospital
Louisville, KY 40202
Director, Thoracic Surgery Residency Program
University of Louisville
Louisville, KY 40202
Director, Heart Transplant and Mechanical Assist Device
University of Louisville/Jewish Hospital
Louisville, KY 40202
Associate Faculty
Bioengineering Department
University of Louisville
Louisville, KY 40202
Certifications:
Mark S. Slaughter, M.D. November 15, 2016
2
Diplomat, National Board of Medical Examiners (#334312) 1987
Diplomat, American Board of Surgery (#37421) 1992
Recertification: (#047360) 2002
Diplomat, American Board of Thoracic Surgery (#5736) 1995
Recertification: (#5736) 2003
Recertification: (#5736) 2013
Licensure:
Illinois, 036-075781 1986
Indiana, 01043482 1995
Kentucky, 42157 2008
Education and Training:
Fellowship
Cardiovascular and Thoracic Surgery 1991-1994
University of Minnesota
University of Minnesota Hospital and Clinic
Minneapolis, MN 55455
Residency
General Surgery 1986-1991
McGaw Medical Center of Northwestern University
Northwestern Memorial Hospital
Chicago, IL 60611
Education
Indiana University School of Medicine 1982-1986
Indianapolis, IN 46202
Purdue University 1978-1982
BS Engineering
West Lafayette, IN 47907
Santa Clara University 1977-1978
Santa Clara, CA 95053
Previous Appointments:
Chair 2014-Present
Department of Cardiovascular and Thoracic Surgery
University of Louisville
Louisville, KY 40202
Professor with Tenure 2014
Department of Cardiovascular and Thoracic Surgery
Mark S. Slaughter, M.D. November 15, 2016
3
University of Louisville
Louisville, KY 40202
Professor of Surgery 2008-Present
Division of Thoracic and Cardiovascular Surgery
University of Louisville
Louisville, KY 40202
Chief 2008-2014
Division of Thoracic and Cardiovascular Surgery
University of Louisville
Louisville, KY 40202
Adjunct Assistant Professor 2007-2008
Department of Physiology and Biophysics
University of Illinois
Chicago, IL 60607
Director Heart Transplantation 2007-2008
Advocate Christ Medical Center
Oak Lawn, IL 60453
President 2001-2008
Cardiac Surgery Clinical Research Center, Inc.
Oak Lawn, IL 60453
Director, Cardiac Transplantation 1996-1998
University of Illinois
Chicago, IL 60607
Director 1998-2008
Cardiac Surgery Research
Advocate Christ Medical Center
Oak Lawn, IL 60453
Clinical Assistant Professor of Surgery 1995-2000
University of Illinois
Chicago, IL 60607
Director 1994-2008
Mechanical Assist Device Program and Surgery
for Congestive Heart Failure
Advocate Christ Medical Center
Oak Lawn, IL 60453
Mark S. Slaughter, M.D. November 15, 2016
4
Cardiothoracic and Vascular Surgical Associates 1994-2008
Advocate Christ Medical Center
Oak Lawn, IL 60453
Honors and Awards:
Department of Cardiovascular and Thoracic Surgery 2015
Teacher of the Year
Business First 2013, 2014
Partners in Health Care
People to Watch
Jewish Hospital & St. Mary’s Hospital Foundation 2011
“Excellence in Education”
ARGI Physician of the Year 2010
Medical News – MediStar Awards
Science Ambassador 2009
Louisville Science Center
Outstanding Physician Leader 2007
Advocate Christ Medical Center
Alley-Sheridan Scholar 1999
Thoracic Surgery Foundation
Understanding the New World of Health Care
Northwestern University 1991
Medical School Outstanding Resident Teacher
Harold L. Method, MD Award 1990
Outstanding Surgical Resident
Northwestern University
Outstanding Surgical Resident 1990
Teacher of the Year
Northwestern University
Academic Achievement Award 1986
Honors Program in Academic Medicine
Indiana University
Senior Elective Honors Program in Surgery 1986
Indiana University
Mark S. Slaughter, M.D. November 15, 2016
5
Summary of Research Productivity:
Grant funding generated as PRINCIPAL INVESTIGATOR = $ 13,710,756
Grant funding generated as CO-INVESTIGATOR = $ 9,780,493
Grant funding TOTAL (PI+CO-I) = $ 23,491,249
Honorary Organizations:
Alpha Omega Alpha
National Honorary Medical Society
Chi Epsilon
Civil Engineering Honor Society
Tau Beta Pi
National Honorary Engineering Society
Vice President
Tau Beta Pi
Purdue University Chapter
Professional Memberships:
American Association of Thoracic Surgeons (AATS)
Education Committee 2013-Present
Ethics Committee 2012-Present
American College of Surgeons
American Heart Association (AHA) 1999-Present
Scientific Statement writing Group 2012
The Importance of Measuring Patient Health Status
CVSA Council 2012-Present
American Medical Association 2011-Present
American Society for Artificial Internal Organs (ASAIO)
Editor in Chief-ASAIO Journal 2013-Present
President 2013-2014
President Elect 2012-2013
Secretary/Treasurer 2011-2012
Program Chair 2011
Mark S. Slaughter, M.D. November 15, 2016
6
Deputy Program Chairman 2009-2010
Executive Committee 2009-Present
Board of Directors 2007-Present
Website Editor 2005-2008
Cardiac Track Annual Meeting Chairman 2006
American Society of Transplant Physicians
American Society of Transplant Surgeons
Heart Failure Society of America
International Society of Heart and Lung Transplantation
Editorial Board 2011-2016
Research Awards Committee 2013-Present
ISHLT MCS Strategy Taskforce 2014-Present
International Society of Rotary Blood Pumps (ISRBP)
President 2013-2014
President Elect 2012-2013
Vice President 2009-2012
Congress Chair, annual Meeting 2011
International Organizing Committee (IFAO/JSAO/ISRBP) 2012
The Society of Thoracic Surgeons (STS)
Network of Experts 2011-Present
STS in collaboration with ACR and ACC 2010
Co-Chair STS University Course on VADs 2008
Abstract Reviewer 2005-Present
STS RUC Five-Year Review Expert Panel 2005
Society of University Surgeons 2013-Present
Southern Thoracic Surgical Association 2008-Present
Councilor at Large 2015-2018
Southern Surgical Association 2011-Present
Professional Service (other):
Kentucky Organ Donor Affiliates (KODA)
Clinical Advisory Committee Member 2009-Present
Association for the Advancement of Medical Instrumentation
Medical Device Particulates Committee 2007-2008
Mechanical Circulatory Support 2007-Present
Device Committee
Mark S. Slaughter, M.D. November 15, 2016
7
American Heart Association
Kentuckiana AHA President 2012-2014
Kentuckiana AHA President Elect 2010-2012
AHA Minority Mentoring System 2008
Mentee: Dr. Juan Carlos Osorio / Columbia University
INTERMACS
Data, Access, Analysis, and Publications (DAAP) 2014-present
Committee Member
UNOS
UNOS – Region 11 2009-2012
Thoracic Review Board
UNOS – Region 7 2006
Thoracic Review Board
CV Member Advisory Council 2007-2008
Gift of Hope Organ & Tissue Donor Network
Kentucky Medical Association (KMA)
Physician Workforce Committee 2011-Present
The Welcome Trust Limited (United Kingdom)
Consultant, Technology Transfer Division 2011
University of Louisville:
Graduate Research Training Faculty as member of 2016-Present
Graduate Faculty of the School of Medicine
University of Louisville 2015-Present
Graduate Faculty, Department of Bioengineering
(Ad Hoc)
University of Louisville 2014-Present
Council of the School of Medicine
University of Louisville 2015-Present
Problem Based Learning
2nd Year Medical Students
University of Louisville Physicians 2014-Present
Board of Directors
University of Louisville 2013
Search Committee
Director Office Technology Transfer
Mark S. Slaughter, M.D. November 15, 2016
8
University of Louisville 2012
Search Committee
Vice Dean for Research
University of Louisville Physicians 2011-2013
Executive Committee
Mock Study Section 2011
“Grantseekers”
University of Louisville
Louisville, KY 40202
Radiology 2011
Chair Review Committee
University of Louisville
Oversight Committee 2011-Present
W.H. Coulter Foundation Translational
Research Partners Program Grant
Bioengineering Department
Integrity in Research Review Committee 2011
Hiram C. Polk Surgical Society Member 2010-Present
School of Nursing Committee
Advisory Board Committee 2009-2015
University Physicians Associates 2009-2010
Consolidation Plan Task Force
Government Agency Advisory Committees:
Special Emphasis Panel (SEP) 2011-Present
Peer Review
SBIR Contracts
NIH/NHLBI
Consultant – FDA 2008-Present
Circulatory System Devices Panel
Grant Reviewer 2007
SBIR/STTR National Science Foundation
Health and Human Services 2002-2007
Medicare Coverage Advisory Committee
Mark S. Slaughter, M.D. November 15, 2016
9
Physician Reviewer 1999-2008
Illinois Foundation for Quality
Healthcare (Medicare)
Editorial Service:
Editor in Chief
ASAIO Journal 2013-Present
Associate Editor
Annals of Thoracic Surgery 2012-Present
Editorial Board
World Journal of Transplantation 2016-Present
Journal of the American College of Cardiology (JACC) 2012-Present
Senior Consulting Editor JACC Heart Failure
The Journal of Heart and Lung Transplantation (JHLT) 2011-2016
Heart Failure Reviews 2011-Present
Journal of Cardiac Surgery 2011-Present
Cardiac and Vascular Regeneration 1999-2002
Angiogenesis and Myogenesis,
Basic Therapeutic
Journal Reviewer
New England Journal of Medicine (NEJM) 2011-Present
Mayo Clinic Proceedings 2010-Present
Circulation 2008-Present
Congestive Heart Failure 2002-Present
Clinical Committees/Consulting:
1. Oregon Heart 2016
Medical Advisory Board
2. Johnson & Johnson 2015
Heart Failure Technology Group
3. Carmat 2013-Present
Scientific Advisory Board
4. CorMatrix Cardiovascular 2011
Data and Safety Monitoring Board (DSMB)
Consultant
5. SUNSHINE HEART 2010-2016
Scientific Advisory Board
6. REVIVE-IT Trial 2011
Protocol Development Committee Member
Mark S. Slaughter, M.D. November 15, 2016
10
7. SCCOR 2010-2012
Medical Management Committee
SCCOR Cell Study
8. External Safety Advisory Board Committee 2009-2011
Data Monitoring Committee (DMC)
Phase II Cardiopulmonary Bypass Surgery Study
Novo Nordisk A/S
9. HeartWare LVAD Trial 2008-2012
National Principle Investigator
10. Novo Nordisk 2009-2011
International Data Safety Monitoring Committee
11. World Heart Corporation 2007-2011
Leavcor ™ Rotary VAD
U.S. Clinical Trial Coordinating Committee
12. Orquis Medical 2007-2008
Exeleras Safety Review Committee
Lake Forest, CA
13. HeartWare, Inc. 2006-2008
Data Safety Monitory board
European Trial
Endowed Lectures/Visiting Professor:
1. Dugan Family Lecturer in Cardiothoracic Surgery, 2nd Annual Dougan Lecture, Oregon
Health Science University, Portland, Oregon, January 22, 2015
2. Kent Trinkle Lecture, Southern Thoracic Surgical Association, Tucson, Arizona,
November 7, 2014.
3. Julian Johnson Lecture, University of Pennsylvania Health System, Philadelphia,
Pennsylvania, May 22, 2014
4. Wilbert J. Keon Endowed Lectureship, University of Ottawa Heart Institute, Ottawa,
Canada,
June 25, 2012.
5. William S. Pierce Endowed Lecture, Sixteenth Annual William S. Pierce Lecture,
Hershey Medical Center, Hershey, PA, May 7, 2012.
Invited Grand Rounds:
1. “The Role of VADs in Advanced Heart Failure and Outpatient Management” Cardiology
Grand Rounds, Central Baptist Hospital, Lexington, KY August 14, 2013.
Mark S. Slaughter, M.D. November 15, 2016
11
2. “Trends & Future Role of Mechanical Circulatory Support in Heart Transplantation”,
Methodist J.C. Walter Jr. Transplant Grand Rounds, Methodist Department Surgery,
Houston, TX, October 10, 2012.
3. “Mechanical Circulatory Support: Alternative to Bridge to Transplant.” Cardiothoracic
Grand Rounds, New York-Presbyterian Hospital/Columbia University, New York, NY,
November 18, 2010.
4. “Mechanical Circulatory Support for Advanced Heart Failure: The Rise of the Machine.”
Christ Hospital in Cincinnati Grand Rounds. September 30, 2010.
Invited Lectures:
1. “The Future of Innovation: Collaborative Effort Between Clinicians, Bioengineering and
Industry.” American Heart Association Scientific Sessions, November 14, 2016, New
Orleans, LA.
2. “Unloading Strategies for Myocardial Recovery.” American Heart Association Scientific
Sessions, November 15, 2016, New Orleans, LA.
3. “Developing New Technology to Avoid the Impending Crisis in Heart Transplantation.”
Samuel Gross Lectureship, University of Louisville School of Medicine, November 7,
2016, Louisville, KY.
4. “Ventricular Assist Device Weaning: the impact of pump settings,” European Mechanical
Circulatory Support Summit, November 3, 2016, Berlin, Germany.
5. “Surgical Approaches to Advanced Heart Failure—What’s New?” INOVA Heart &
Vascular Institute, Advanced Heart Failure Symposium, October 21, 2016, Alexandria,
VA.
6. “VAD Therapy Play in the Treatment of Patients with Advanced Heart Failure,”
American College of Cardiology, Kentucky Chapter Annual Meeting, October 8, 2016,
Lexington, KY.
7. “Lessons Learned From Endurance, Roadmap/Medimacs and How To Go Forward”
European Training Symposium, June 24, 2016, Berne, Switzerland.
8. “Hot Topics in VAD Research” ASAIO, June 17, 2016, San Francisco, CA.
9. “Potential Use of HeartMate III and HeartWare MVAD in Children” ASAIO, June 15,
2016, San Francisco, CA.
10. “Extracorporeal Support- the Sooner the Better” AATS May 15, 2016, Baltimore, MD.
Mark S. Slaughter, M.D. November 15, 2016
12
11. “Basic Review of Flow, Shear and Basic MCS design and Subsequent Impact on
Coagulopathies and Other Adverse Events” ISHLT, April 29, 2016 Washington D.C.
12. “Cardiovascular Locum Tenens: Time to Reconsider” Society for Thoracic Surgical
Education, April 21, 2106, Key West, FL.
13. “HVAD Pump Wet Lab” HeartWare Fellows Forum, March 19, 2016 Boston, MA
14. “Mechanical Circulatory Support: Technology Evolution and Overhead of the HVAD
Pump” HeartWare Fellows Forum, March 18, 2016 Boston, MA
15. “Cardiac Mechanical Assist Course for the ICU” Association of Physician Assistants in
Cardiovascular Surgery 35th Annual Meeting, March 13, 2016 Las Vegas, NV.
16. “Advances in VAD Technology: HeartMate III, Heartware MVAD”, Cedars-Sinai Heart
Institute Symposium -An International User’s Guide to Mechanical Circulatory Support,
October 9-10, 2015, Los Angeles, CA.
17. “Alternative Surgical Techniques for Implantation, Exchange and Explanation in Long
Term LVADS” International Society for Heart and Lung Transplantation, April 14,
2015, Nice, France.
18. “Mechanical Circulatory Support Patient Selection: Changing Paradigms, Less Ill
Patients for LVAD Therapy” 8th Branislav Radovancevic International Symposium for
Innovations and New Treatment Strategies in Heart Failure, September 24, 2015,
Budapest, Hungary
19. “Current Topics in Regeneration Medicine in End Stage Heart Failure”, 45th Annual
Japanese Society for Cardiovascular Surgery, February 15, 2015, Kyoto, Japan.
20. “Myocardial Recovery; Fact, Fiction and Future Directions” European Association for
Cardio-Thoracic Surgery, November 11th-14th, 2014, London, England.
21. “What is Important to Know About LVAD Therapy” 2nd Annual European Training
Symposium, June 27th-28th, 2014, Berne, Switzerland.
22. “What’s New in LVAD: Hemolysis and Thrombosis” 2nd Annual European Training
Symposium, June 27th-28th, 2014, Berne, Switzerland.
23. “Do We Need Physiologic VAD Control And Flow Estimation For Improved Patient
Care?” ASAIO 60th Annual Conference, June 18th – 21st, 2014, Washington, DC.
24. “Wrong Pump, Wrong Time” ASAIO 60th Annual Conference, June 18th – 21st, 2014,
Washington, DC.
25. “Surgical Approaches in Post-Op Care” ASAIO 60th Annual Conference, June 18th – 21st,
2014, Washington, DC.
Mark S. Slaughter, M.D. November 15, 2016
13
26. “Live in a Box, How I Do It: New Innovations in LVAD Therapy” ISMICS Master’s Day
Program, May 27th – 28th, 2014, Boston, Massachusetts.
27. “HeartWare MVAD and TMVAD” ISMICS Master’s Day Program, May 27th – 28th,
2014, Boston, Massachusetts.
28. “Risk Factors for Adverse Outcomes with HeartWare HVAD” INTERMACS 8th Annual
Meeting, May 4th – 5th, 2014, Arlington, Virginia.
29. “Matching Pumps to Patients: Considerations for Device Type, Type of Flow Based
Upon Patient Factors” 94th Annual AATS Meeting, April 25th – 29th, 2014, Toronto,
Canada.
30. “Research and Technology Advisory Group (RTAG) and CIRI” CVSL April Quarterly
Meeting April 21st-23rd, 2014, Naples, Florida.
31. “Myocardial Regeneration and Recovery with Extracellular Matrix and LVAD Support”.
34th Annual ISHLT Meeting. April 13, 2014.
32. “Early Post-op anticoagulations: Is It Needed and What to Use?” 34th Annual ISHLT
meeting. April 10, 2014, San Diego, CA.
33. “HeartWare” Small group Session ISHLT Academy MCS Meeting pre 34th Annual
ISHLT Meeting. April 8th, 2014. San Diego CA
34. “Tailoring Pumps to Patients” Surgical Considerations- ISHLT Academy MCS Meeting-
34th Annual ISHLT Meeting. April 7th, 2014. San Diego CA
35. “Left Ventricular and Vascular Biomechanics in Advanced Heart Failure Patients
Supported by Continuous and Pulsatile Left Ventricular Assist Devices”, Quick Shot
Presentation at Academic Surgical Congress 2014 9th Annual Meeting, San Diego, CA,
Feb 4th, 2014-Presented by Dr. Allen Cheng.
36. “CARMAT Bioprosthetic Hydraulic Total Artificial Heart”. STS/AATS Tech Con 2014
Annual Meeting January 26, 2014. Orlando, FL
37. “Surgical Tribulations of a Heart Failure Patient: VAD + Transplant” Case Theatre
Presentation, AHA Scientific Sessions 2013 Annual Meeting. Dallas, TX, November 18,
2013
38. “State of the Art LVADs”, Leading the Round Table Discussion: TV Studio at EACTS
Annual Meeting, Vienna, Austria. October 8, 2013.
39. “Long Term Circulatory Support with Rotary Blood Pumps: Is it worthwhile?”
Discussant at EACTS Annual Meeting, Vienna, Austria. October 8, 2013.
Mark S. Slaughter, M.D. November 15, 2016
14
40. “Destination Life on Device”, Key Note Speaker -Symposium Heart 4: ISRBP 2013
Annual Meeting, Yokohama Japan, September 28, 2013
41. “Less Invasive Surgery of RBPs” ISRBP 2013 Annual Meeting, Yokohama, Japan.
September 27, 2013.
42. “Current International Status of RBP: Clinical Results of Long Term Support with RBP”.
ISRBP Annual Meeting, Yokohama, Japan. September 26, 2013.
43. “Expanding Indications for LVADs from Support to Cell-Based Therapies” Greater
Milwaukee Heart Failure Society, Aurora St. Luke’s Medical Center. August 19, 2013.
44. “Device Options for Severe Biventricular Failure”, Comprehensive Advanced Heart
Failure Summit, Vanderbilt Heart and Vascular Institute, Vanderbilt University,
Nashville, TN. August 10, 2013.
45. “Centrifugal Flow Physiology: Technical and Clinical Implications, Data Update, and
Strategies to Improve Outcomes”, HeartWare HVAD Clinician Forum. Toronto, Ontario,
CAN, July 27, 2013.
46. “What are the Clinical Contraindications to Destination Therapy in the Current Era?”
Gordon Research Conference 2013, Renaissance Tuscany, Lucca (Barga), Italy. June 26,
2013.
47. General Session 2: Co-Chair, American Society for Artificial Internal Organs 2013 59th
Annual Meeting. Chicago, IL, June 14, 2013.
48. “The Future of VAD Therapy”, American Society for Artificial Internal Organs 2013 59th
Annual Meeting, VAD Coordinator Session 2. Chicago, IL, June 14, 2013.
49. “Continuous Flow Pumps” Co-Chair Moderator, American Society for Artificial Internal
Organs 2013 59th Annual Meeting, Chicago, IL, June 13, 2013.
50. “The Future of Mechanical Circulatory Support”, American Society for Artificial Internal
Organs 2013 59th Annual Meeting, General Session 1: Measuring Success: Medical
Devices & Organ Failure. Chicago, IL, June 13, 2013.
51. “Implantation of Latest Generation Ventricular Assist Devices”, American Association
for Thoracic Surgery 2013 Adult Cardiac Skills and Decision Making Course,
Minneapolis, MN, May 4, 2013.
52. “JHLT at the ISHLT: The Year in a Capsule Discussion: Highlights of Heart
Transplantation and Mechanical Circulation” ISHLT 33rd Annual Meeting, Montreal,
Canada. April 26, 2013.
53. “Matching Pumps to Patients: Considerations for Device Type & Type of Flow Based
Upon Patient Factors”. ISHLT 33rd Annual Meeting, Montreal, Canada. April 23, 2013.
Mark S. Slaughter, M.D. November 15, 2016
15
54. “Alternative Techniques for LVAD Implantation” Annual Society of Thoracic Surgical
Education Meeting. Walland, Tennessee, April 20th, 2013.
55. “Marginal Donors for Heart Transplantation: What are they and Does it Matter?” Annual
Society of Thoracic Surgical Education Meeting. Walland, Tennessee, April 19th, 2013.
56. “Heart Failure: Cells to LVADs”, Big East Cardiovascular Symposium, Clinical
Research: The Cornerstone of Future Treatments for Cardiovascular Disease. New
York, NY, March 15th, 2013.
57. “SBIR: A More Viable NIH Grant Option?”, SBIR/AATS Workshop, Bethesda,
Maryland. March 8th, 2013.
58. “What Will the VAD World Look Like in 3 - 5 Years?” The Society of Thoracic
Surgeons 49th Annual Meeting, Los Angeles, CA, January 29, 2013.
59. “ADVANCE Trial Update”, The Society of Thoracic Surgeons 49th Annual Meeting, Los
Angeles, CA, January 29, 2013.
60. “Does the type of unloading device (pulsatile, continuous, counterpulsatile) matter?”
Utah Cardiac Recovery Symposium, Salt Lake City, UT, January 19, 2013.
61. “Destination VADS Should Only Be Done In A Transplant Center (Con Position)”,
Southern Thoracic Surgical Association, Naples, FL, November 8, 2012.
62. “Generation Skipping: VADs, Valves and Devices”, American Heart Association 2012
Scientific Sessions, Los Angeles, CA, November 7, 2012.
63. “Recovery Is Real: Management Tactics and Operative Techniques”, American Heart
Association 2012 Scientific Sessions, Los Angeles, CA, November 6, 2012.
64. “Transapical LVAD Implantation”, 26th European Association for Cardio-Thoracic
Surgery Annual Meeting, Barcelona, Spain, October 27, 2012.
65. “Should Patients on Long Term ‘Destination Therapy’ be Listed for Transplant? Under
What Condition and What Status?”, 15th Heart Failure Summit: 21st Century Treatment
of Heart Failure: Synchronizing Surgical and Medical Therapies for Better Outcomes”,
Cleveland, OH, October 19, 2012.
66. “Cost of Implant, Comparators and Effectiveness”, VAD Economic Summit, Dallas, TX,
September 27, 2012.
67. “Mechanical Circulatory Support for End-Stage HF: When it is Too Late to Implant a
RBP?”, 20th Congress of the International Society for Rotary Blood Pumps (ISRBP),
Istanbul, Turkey, September 20, 2012.
Mark S. Slaughter, M.D. November 15, 2016
16
68. “Short-Term Device Strategies for Acute Cardiac Failure: What to Do When Medications
Fail?” Heart Failure Society of America (HFSA) Annual Scientific Meeting, Seattle, WA,
September 9, 2012.
69. “VAD Destination Trials”, 4th Alfred ICU International Symposium on ECMO & VAD
Support in Critical Care, Melbourne, AU, July 19, 2012.
70. “Marginal Cardiac Donors”, 4th Alfred ICU International Symposium on ECMO & VAD
Support in Critical Care, Melbourne, AU, July 18, 2012.
71. “Fine Tuning Pumps”, 32nd Annual Meeting of the International Society of Heart & Lung
Transplantation, Prague, Czech Republic, April 18, 2012.
72. “Matching Pumps to Patients”, 32nd Annual Meeting of the International Society of Heart
& Lung Transplantation, Prague, Czech Republic, April 17, 2012.
73. “The Failing Heart - Update in Device Therapy”, Cardiology Colloquium, Kettering CV
Institute, Wright State University School of Medicine, Dayton, OH February 29, 2012.
74. “HeartWare: Results of the ADVANCE Bridge to Transplant Trial.” EACTS
Meeting, Lisbon, Portugal, October 2, 2011.
75. “Controversial Issues in heart Failure Device Treatment.” “Brano” Heart Failure
Forum, Belgrade, Serbia, October 1, 2011.
76. “Historical Development of Mechanical Circulatory Support.” NY State Chapter of
the American College of Cardiology, Rochester, NY, September 24, 2011.
77. “Needs for RVAD: None, Temporary or Permanent.” HFSA, Boston, MA,
September 21, 2011.
78. “Pre-Clinical Reliability Testing.” STS/FDA VAD Symposium, Washington, D.C.,
September 16, 2011.
79. “What Is The Lower Limit of Anticoagulation Necessary For The Current Generation of
Durable MCS Devices?” ISHLT Annual Meeting, San Diego, CA, April 16, 2011.
80. “Cardiovascular Disease in Kentucky.” Jewish Hospital Foundation Board of Directors,
Louisville, KY, April 11, 2011.
81. “Bridges and Destinations: Ventricular Assist Devices in the Current Era.” ACC Annual
Scientific Session, New Orleans, LA, April 5, 2011.
82. “Should Status 1B Patients With a VAD Be Transplant?” Texas Heart Institute Annual
Summit Meeting, Houston, TX, March 12, 2011.
83. “Cardiovascular Disease in Kentucky.” Rotary Club, Louisville, KY, February 24, 2011.
Mark S. Slaughter, M.D. November 15, 2016
17
84. “Historical Development of Mechanical Circulatory Support.” Optimal Treatment
Strategies for Advanced Heart Failure, Mayo Clinic, Scottsdale, AZ, February 12, 2011.
85. “Destination Therapy: The New Paradigm.” Optimal Treatment Strategies for Advanced
Heart Failure, Mayo Clinic, Scottsdale, AZ, February 12, 2011.
86. “Management of Anticoagulation Following Ventricular Assist Device Placement.” 8th
Vail Cardiothoracic Transplantation An International Update, Vail, CO, January 24,
2011.
87. “New Trends and Indications in LVAD Support.” Southern Thoracic Surgical
Association, Lake Buena Vista, FL, November 4, 2010.
88. “Heart Transplant vs. Left Ventricular Assist Device (LVAD) in Heart Transplant
Eligible Patients.” Southern Thoracic Surgical Association, Lake Buena Vista, FL,
November 6, 2010.
89. “Advanced Heart Failure Treated with Continuous Flow Left Ventricular Assist
Device.” American Heart Association Scientific Sessions 2010, Chicago, IL,
November 14, 2010.
90. “Extracorporeal Devices.” American Heart Association Scientific Sessions 2010,
Chicago, IL, November 14, 2010.
91. “ECMO Support Moderator. First International Congress on ECMO Therapy in
Cooperation with ASAIO.” Harrisburg, PA. May 26, 2010
92. “Current Economics and Regionalization for VAD Therapy in Advanced Heart
Failure.” Society for Thoracic Surgical Education. Sedona, AZ. March 12, 2010.
93. “Expanding the number of VAD centers: Problems and Pitfalls.” Texas Heart
Institute Symposium. Houston, TX; March 6, 2010.
94. “Advances in Patient Outcomes.” Thoratec Destination Life: Advanced Heart
Failure Therapy in the New Era. Chandler, AZ; February 20, 2010.
95. “VAD Update – Thoratec: HeartMate II.” European Mechanical Support Summit.
Paris, France; December 3, 2009.
96. “Surgical Management of Driveline and Pocket Infection”. The Harefield VAD
Clinical Management Course, Denham, UK; October 4, 2009.
97. “Device Selection: Clinical Aspects.” The Harefield VAD Clinical Management
Course, Denham, UK; October 3, 2009.
Mark S. Slaughter, M.D. November 15, 2016
18
98. “Surgical Technique: Long Term Devices.” The Harefield VAD Clinical
Management Course, Denham, UK; October 3, 2009.
99. “Is Mechanical Circulatory Support Going to be Limited to Large Transplant
Centers?” Thoratec Economic Summit, Dallas TX; October 1, 2009.
100. “Do Patients Require Replacement of the Entire Circulation? The potential for
Partial Circulatory Support.” Heart Failure Society of America, Boston, MA;
September 15, 2009.
101. “Partial vs. Full MCS for Cardiogenic Shock.” Gordon Research Conference,
Waterville Valley, NH; September 8, 2009.
102. “What Have We Learned About Continuous Flow Pumps?” Cardiovascular
Care: Legacy and Innovation, Cleveland, OH; June 4, 2009.
103. “FORCEfield”™ Novel Technology for Surface Treatment of Mechanical Heart
Valves for Inhibition of Platelet Adhesion.” ACTS 2009, New York, NY; May 6,
2009.
104. “Mechanical Circulatory Support: The Future for End-Stage Heart Failure.” 21st
Century Treatment of Heart Failure: Utilizing Medical and Surgical Therapies for
Optimal Outcomes Symposium, Louisville, KY; April 16, 2009.
105. “Heart Pumps: Current and Future Technologies for Cardiovascular Support.” 3rd
Annual Cardiovascular System Symposium, Louisville, KY; March 5, 2009.
106. “Long-Term Mechanical Support: What is the Next Step?” The American
Academy of Cardiovascular Perfusion, Dallas, TX; February 7, 2009.
107. “Mechanical Circulatory Support: The Future for End-Stage Heart Failure.”
Grand Rounds. St. Mary’s Hospital, Evansville, IN; February 4, 2009.
108. “Contemporary Experience with New Pumps – HeartWare.” Cleveland Clinic
21st Century Treatment of Heart Failure, Cleveland, OH; October 18, 2008.
109. “Design Concepts and Initial Tests of a Prototype Mechanical Circulatory
Support Device from HeartWare.” ISRBP Meeting, Houston, TX; October 3, 2008.
110. “New Surface Treatment of Mechanical Heart Valves.” EACTS Meeting,
Lisbon, Portugal; September 13, 2008.
111. “Echocardiography: A Vital Tool for the Appropriate Use of Ventricular Assist
Devices.” Echo Society Meeting, Lincolnshire, IL; July 2, 2008.
112. “Mechanical Circulatory Support for End Stage CHF.” University of California
San Francisco, San Francisco, CA; June 19, 2008.
Mark S. Slaughter, M.D. November 15, 2016
19
113. “Mechanical Circulatory Support for Advanced Heart Failure.” Elkhart General
Hospital, CME Event, Elkhart, IN; June 11, 2008.
114. “Surgical Approaches to End-Stage Heart Failure.” Grand Rounds. Hartford, CT;
June 5, 2008.
115. “Bleeding takes Center Stage: Strategies to decrease bleeding during implant and
transplant.” BTMCS 2008, Vienna, Austria; May 17, 2008.
116. “State of the Art Anticoagulation Regimens in MCS.” BTMCS 2008, Vienna,
Austria; May 17, 2008.
117. “Mechanical Circulatory Support for Advanced Heart Failure.” Cardiovascular
Symposium, Community Hospital, Munster, IN; April 19, 2008.
118. “Current Outcomes in Destination Therapy.” ISHLT 28th Annual Meeting and
Scientific Sessions, Boston, MA; April 9, 2008.
119. “Partial Assist Pumps.” Texas Heart Institute, Rodeo Meeting, Houston, TX;
March 7-8, 2008.
120. “Mechanical Circulatory Support for Congestive Heart Failure.” Grand Rounds,
University of Louisville, Louisville, KY; February 27, 2008.
121. “Device Update on HeartMate II.” EUMS – 2nd European Mechanical
Circulatory Support Summit, Paris, France; November 30, 2007.
122. “Permanent Mechanical Circulatory Support Vs. Transplantation: Is the
Difference Real or Artificial?” 21st Century Treatment of Heart Failure:
Synchronizing Surgical and Medical Therapies for Better Outcomes,
AATS/ACC/Cleveland Clinic, Cleveland, OH; October 20, 2007.
123. “The Future of Mechanical Support: Destination Therapy, Where are We?”
CCTSS/ISPS 2008 Meeting, Advocate Christ Medical Center, Oak Lawn, IL;
October 13, 2007.
124. “Transplantation and Mechanical Circulatory Support for End-Stage CHF.”
Grand Rounds, Memorial Hospital, South Bend, IN; September 26, 2007.
125. “Destination Therapy: The New Frontier in the Treatment of End-Stage Heart
Failure.” Munster Community Hospital, Munster, IN; September 6, 2007.
126. “Mechanical Circulatory Support for Advanced Heart Failure.” Grand Rounds,
Munster Community Hospital, Munster, IN; June 27, 2007.
Mark S. Slaughter, M.D. November 15, 2016
20
127. “Regulatory Issues Surrounding Heart Failure Devices.” HFSA, Bethesda, MD;
May 31-June 1, 2007.
128. “Anticoagulation Management Issues with Axial Flow Devices: HeartMate II.”
ISHLT, San Francisco, CA; April 25-28, 2007.
129. “Building a Destination Therapy Practice.” ISHLT, San Francisco, CA; April 25-
28, 2007.
130. “A Congestive Heart Failure Survey of Illinois Physicians: What Do They Know
That We Don’t?” Texas Heart Institute, Houston, TX; March 2-3, 2007.
131. “Destination Therapy: Current Outcomes and Future Hurdles.” Advocate Illinois
Masonic Medical Center, Chicago, IL; February 3, 2007.
132. “Mechanical Assist Circulatory Support for Patients with End Stage Heart
Failure.” St. Catherine Hospital, East Chicago, IN; January 18, 2007.
133. “Destination Therapy Improved Outcomes with HeartMate II LVAD.” European
Mechanical Circulatory Support Summit, Bad Oeynhausen, Germany; December 6-
9, 2006.
134. “Long Term Use for Mechanical Assist Device Support: Updates and Current
Outcomes.” Grand Rounds, Advocate Christ Medical Center, Oak Lawn, IL;
October 5, 2006.
135. “Mechanical Heart Replacement: Ready for Prime Time.” Midwest Heart
Foundation, Congestive Heart Failure Symposium, Lake Geneva, WI; September
15-16, 2006.
136. “Reducing Emboli in Cardiac Surgery: Does it Make a Difference?” 16th World
Congress of the World Society of Cardiothoracic Surgeons, Ottawa, Canada; August 19,
2006.
137. “Ventricular Assist Device Support and Myocardial Recovery.” Specialty Review in
Pediatric Cardiology, Chicago, IL; August 19, 2006.
138. “The Ideal Control System for Mechanical Blood Pumps.” ASAIO; June 10, 2006.
139. “Mechanical Circulatory Support: Current Indications & New Devices.” Grand
Rounds, Lancaster, PA; February 28, 2006.
140. “VAD Destination Therapy is Ready for Prime Time.” STS/AATS Tech Con,
Chicago, IL; January 28, 2006.
141. “LVAD’s for Permanent Use: Surgical Therapy for End-Stage CHF.” 9th Annual
Mark S. Slaughter, M.D. November 15, 2016
21
Update in Cardiovascular Disease: Advances in the Management of Congestive Heart
Failure, Oak Brook, IL; October 29, 2005.
142. “Ventricular Assist Devices.” 10th Annual Illinois State Perfusion Society Meeting,
Loyola University, Chicago, IL; October 8, 2005
143. “Contemporary Outcomes with Mechanical Circulatory Support Devices and
Economic Implications.” Heart Failure Society of America, Boca Raton, FL; September
18, 2005.
144. “Surgical Therapies for Heart Failure.” 12th Annual Cardiovascular Symposium at
Eagle Ridge Conference Center, Galena, IL; September 10, 2005.
145. “Surgical Therapies for Heart Failure.” 4th Annual Deep in the Heart of Texas-
Congestive Heart Failure Symposium, San Antonio, TX; February 5, 2005.
146. “Where are the DT Patients? Why Aren’t We Seeing Them? What Can We Do?”
Building a Successful Destination Therapy Program, Tampa, FL; January 23, 2005.
147. “Destination Therapy: Current Outcomes.” Lutheran General Cardiology Grand
Rounds, Park Ridge, IL; November 2, 2004.
148. “Can We Push the Envelope on Home Discharge?” The Heart of the
Matter: Improving Clinical Outcomes for Patients with End-Stage Heart Failure
Symposium, Hollywood, FL; October 21-23, 2004.
149. “Debate: DT is ready for Prime Time.” The Heart of the Matter: Improving Clinical
Outcomes for Patients with End-Stage Heart Failure Symposium, Hollywood, FL;
October 21-23, 2004.
150. “Educating Our Referral Sources about Destination Therapy.” Current Strategies in
Heart Failure Management: Drugs to Devices. Louisville, KY; August 27-29, 2004.
151. “Destination Therapy: Past, Present and Future.” Upstate New York Heart Failure
Symposium, Rochester, NY; May 1, 2004.
152. “Converge Medical Distal Sutureless Anastomotic System.” FDA Panel Presentation,
Washington, DC; March 18, 2004.
153. “Surgical Alternatives to Heart Failure.” Congestive Heart Failure: Innovations in
Medical & Surgical Therapy, Chicago, IL; February 21, 2004.
154. “Home Discharge with Thoratec TLC-II.” Thoratec Worldwide Sales Meeting,
Phoenix, AZ; January 18-22, 2004.
155. “Destination Therapy: Current Results and Future Hurdles.” Thoratec Worldwide
Sales Meeting, Phoenix, AZ; January 18-22, 2004.
Mark S. Slaughter, M.D. November 15, 2016
22
156. “Ventricular Assist Device (VAD) for End Stage Heart Failure.” Advocate Christ
Medical Center Nursing Grand Rounds. Oak Lawn, IL; December 2, 2003.
157. “LVADs & Destination Therapy: Has the Future Arrived?” Advanced Strategies in
the Treatment & Management of Heart Failure, Philadelphia, PA; November 22, 2003.
158. PTCA vs. Surgical Revascularization in Young Adults.” 5th International Congress on
CAD, Florence, Italy; October 19-22, 2003.
159. “Robotic Mitral Valve Repair: Improved Results and Patient Satisfaction.” 3rd World
Congress on Heart Disease-New Trends in Research, Diagnosis and Treatment,
Washington, DC; July 12-15, 2003.
160. “Permanent Mechanical Assist Device Support.” European Society of Cardiology,
International Society for Heart Research Symposium. Heart Failure 2003, Strasbourg,
France; June 21, 2003.
161. “Single Center Results of the Thoratec VAD TLC-II System: Outpatient Experience.”
Illinois State Perfusion Society, Oak Lawn, IL; April 12th, 2003.
162. Surgical Treatment of Congestive Heart Failure.” ISPS, Oak Lawn, IL; April 12th,
2003.
163. Surgical Therapies for Heart Failure: LVADs, Restraint and Beyond.” CME activity
for Heart Failure Update 2003, Oakbrook Terrace, IL; February 12, 2003.
164. “Robotic Mitral Valve Repair Surgery with the daVinci™.” Surgical System
Symposium, Chicago, IL; November 21, 2002.
165. “Bridge to Recovery: Alternative to Cardiac Transplantation?” Mechanical Assist
Device Support for Advanced Heart Failure: Has the Future Arrived? Chicago, IL;
November 16, 2002.
166. “Mechanical Complications of Acute Myocardial Infarction.” Grand Rounds, Christ
Hospital and Medical Center, Oak Lawn, IL, September 12, 2002.
167. “Ventricular Assist Device Support: New Indications and Patient Management.”
Grand Rounds, Maine Medical Center, Portland, ME; August 29, 2002.
168. “Skinned Myocyte Contractile Function in Patients with LV Dysfunction: Predictor of
Myocardial Recovery.” 8th World Congress on Heart Failure- Mechanisms and
Management, Washington, DC; July 14, 2002.
169. “TLC-II Home Discharge Trial.” Thoratec Corporation Investigators and Users
Meeting, Scottsdale, AZ; May 17, 2002.
Mark S. Slaughter, M.D. November 15, 2016
23
170. “Coronary Artery Bypass Grafting vs. Stenting for Multi-Vessel CAD.” Grand
Rounds, Christ Hospital & Medical Center, Oak Lawn, IL; January 25, 2001.
171. Preliminary Experience with a New Synthetic Coronary Artery Bypass Graft (ARIA).”
New Era Cardiac Surgery, Laguna Niguel, CA; January 7, 2001.
172. “Thoratec LVAD Insertion and Patient Management.” Baylor College of Medicine,
Dallas, TX; November 4, 2000.
173. “Left Ventricular Mechanical Assist & Myocardial Recovery.” Chicago Educational
Symposium, Chicago, IL; October 12, 2000.
174. “Steroids and the Systemic Inflammatory Response of Cardiopulmonary Bypass.”
Illinois State Perfusion Society 2000 Annual Meeting, Oak Lawn, IL; March 4, 2000.
175. “The Effect of the New UNOS Listing Criteria on Patients with Mechanical Assist
Devices at Non-Transplant Programs.” HeartMate Investigators and Users Meeting;
Tampa, FL; October 26, 1999.
176. “LVAD for Myocardial Recovery in Dilated Cardiomyopathy.” The Dr. Arfan Al-
Hani Cardiology Symposium, St. James Hospital, Chicago Heights, IL; October 16,
1999.
177. “Use of LVAD for Planned Bridge to Recovery. An alternative to Cardiac
Transplantation.” VAD Symposium, Los Angeles, CA; September 18, 1999.
178. “Improved Clinical Utility: The Thoratec VAD System.” Thoratec VAD Symposium,
Chicago, IL; June 19, 1999.
179. “The Changing Donor and its Effect on Thoracic Organ Procurement.” UNOS Region
7 Forum, Chicago, IL, April 8, 1999.
180. “Hemodynamic Management of the Thoracic Organ Donor.” ROBI (Regional Organ
Bank of Illinois), Chicago, IL; October 19, 1998.
181. “Surgical Therapy for Congestive Heart Failure.” Bloomington Hospital,
Bloomington, IN; April 10, 1998.
182. “Current Surgical Therapy for End-Stage Heart Failure.” Midwest Clinical
Conference, Chicago, IL; February 20, 1998.
183. “HeartMate: Indications and Outcomes of Left Ventricular Assist.” Grand Rounds,
Christ Hospital and Medical Center, Oak Lawn, IL; December 4, 1997.
184. “Left Ventricular Assist Devices: Bridge to Transplantation and Beyond.” The
Chicago Summer Educational Symposium, Chicago, IL; August 28, 1997.
Mark S. Slaughter, M.D. November 15, 2016
24
185. “Cardiac Transplantation: Current Indications and Outcomes.” Grand Rounds,
University of Illinois, Chicago, IL; January 2, 1997.
Medical School/Students Lectures:
1. “Biomedical Device Design: From Bench to Bedside,” University of Louisville School of
Medicine, Louisville, KY, September 2, 2016.
2. “Mechanical Circulatory Support for Heart Failure: Where are we and what is in the
Future?” University of Louisville, Cardiology Grand Rounds, Louisville, KY; January
18, 2012.
3. “New Frontiers in Cardiothoracic Surgery: The Role of Left Ventricular Assist
Devices in the Treatment of Heart Failure.” University of Louisville Bench to
Bedside Lecture, Louisville, KY; June 21, 2011.
4. “Current Treatments for Advanced Heart Failure: The Dawn of a New Era.” Jewish
Hospital Heart and Lung Institute “The Louisville Heart Failure Forum,” Louisville, KY,
June 17, 2011.
5. “Adult ECMO for ARDS.” Grand Rounds, Department of Surgery, University of
Louisville, Louisville, KY, April 8, 2011.
6. “Recent Advances in Mechanical Circulatory Support and Research Opportunities for
Medical Students.” Freshman/Sophomore Surgical Club Dinner, The Olmsted,
Louisville, KY, March 22, 2011.
7. “The Rise of the Machine: Iterative Engineering in LVADs.” University of
Louisville Bench to Bedside Lecture. Louisville, Ky. July 1, 2010.
8. “Mechanical Circulatory Support for Advanced Heart Failure: The Rise of the
Machine.” University of Louisville Cardiovascular Medicine Grand Rounds.
Louisville, KY; January 13, 2010.
9. “Managing the Pulseless Patient.” Pulmonary/Critical Care Grand Rounds.
University of Louisville, Louisville, KY; October 30, 2009.
10. “Mechanical Heart Pumps are the Future of Heart Failure.” Glefand Invited
Lecture. Phi Delta Epsilon, Louisville, KY; December 10, 2008.
11. “Surgical Therapy for End-Stage Lung Disease: Transplant to Artificial Lungs.”
Pulmonary Division, University of Louisville, Louisville, KY; November 25, 2008.
12. “Mechanical Circulatory Support: The Future for End-Stage Heart Failure.”
University of Louisville Department of Surgery Grand Rounds, Louisville, KY;
October 10, 2008.
Mark S. Slaughter, M.D. November 15, 2016
25
Grant Support:
Pending:
OGMB140654
(PI: Slaughter)
Genetic Risk Factors of Sudden Cardiac Death in African Americans
$54,468
Active:
R44HLxxxxxx-01 (PI: Slaughter & Soucy)
9/1/2014-8/31/2017
NIH SBIR phase I-II Grant (*Submitted 12/5/2013)
$1,721,033
Development of P-ECM Intra-Myocardial Delivery System for Heart Failure Therapy
R44HLxxxxxx-01 (PI: Slaughter & Koenig) 5/1/2014-4/30/2017
NIH SBIR phase I-II Grant (*Score = 20) $1,715,801
Development of SVAD for HF Therapy(PI: Soucy) 1/1/2013-12/31/2016
(Co-PI: Mark Slaughter) $308,000
AHA National Scientist Development Award
Role of Diminished Pulsatiility
OICN111220(PI: Emma Birks) 3/1/2013- 1/1/2017
(Co-PI: Mark Slaughter) $889,585
REVIVE-IT Trial: Randomized Evaluation of VAD Intervention before Inotropic
Therapy
1R01HL112595-01A1 1/1/2013 – 12/31/2015
(PI: Slaughter & Koenig) $1,926,960
NIH SBIR phase I and II (fastrack) Grant
KSTC-17-OICS-189 1/1/2013-12/31/2015
(PI: Spence, Koenig, Slaughter) $500,000
Kentucky Science and Technology Corporation (KSTC) Grant
Counterpulsation device with integrated EKG sensing
R44 HL103014-01 4/1/2013 –3/31/2015
(PI: Slaughter & Koenig) $3,619,885
NIH SBIR phase II Grant
Development of transapical MVAD for HF therapy
1R44HL117426-01 1/1/2013 –12/31/2015
(PI: Slaughter & Koenig) $2,846,467
NIH SBIR phase I and II (fastrack) Grant
Mark S. Slaughter, M.D. November 15, 2016
26
Apical access system with universal connector for beating heart
LVAD implantation
(PI: Dr. Bolli) 3/1/2012-3/31/2019
(Co-PI: Mark Slaughter) $3,439,793
Regional Clinical Centers for the Cardiovascular Cell Therapy Research Network
CCTRN
2R43HL102981-02A 4/1/2012 – 3/31/2014
(PI: Koenig & Slaughter) $1,616,503
NIH SBIR Phase II Grant
Subcutaneous ECG Sensing
OGMB110749A3 8/1/2012 – 7/31/2013
(Co-PI: Mark Slaughter) $119,782
Wallace H. Coulter Foundation
Left Atrial Appendage Closure Device
Industry Contract 7/1/2012 – 6/30/2014
(PI: Koenig, Slaughter) $70,000
CorMatrix (Atlanta, GA)
MCS Device Testing
Coulter Foundation 2011-Present
(Co-PI: Mark Slaughter) $5,000,000
Coulter Foundation Translational Research Program
Industry Contract
(PI: Slaughter, Koenig) 12/1/2011 – 12/31/2014
HeartWare $750,000
MCS Device Testing
Industry Contract 7/1/2012 – 6/30/2014
(PI: Slaughter, Koenig) $100,000
HeartWare
MCS Device Testing
Industry Contract 4/1/2012 – 4/30/2013
(PI: Slaughter, Giridharan) $39,056
Thoratec
Thoratec pilot hemolysis testing
Industry Contract
(PI: Slaughter, Koenig) 8/1/2011 – 12/31/2012
Thoratec $434,636
MCS Device Testing
Mark S. Slaughter, M.D. November 15, 2016
27
Industry Contract
(PI: Slaughter, Koenig) 8/1/2011 -12/31/2012
Thoratec $192,882
MCS Device Testing
Industry Contract
(PI: Slaughter, Koenig) 8/1/2011 – 12/31/2012
CorMatrix $106,701
ECM Emulsion Testing
Industry Contract 4/1/2010 – 3/31/2013
(PI: Slaughter, Koenig) $100,000
Abiomed
MCS Device Training
Industry Contract 4/1/2010-3/31/2013
(PI: Slaughter) $250,000
HeartWare (Miramar, FL)
MCS Device Training
Industry Contract 4/1/2010 – 3/31/2013
(PI: Slaughter) $250,000
Thoratec (Pleasanton, CA)
MCS Device Training
Industry Contract 4/1/2010 – 3/31/2013
(PI: Slaughter) $100,000
WorldHeart
MCS Device Training
Completed
R43 HL103014-01A1 4/1/2011-9/30/2012
(PI: Slaughter & Koenig) $413,922
NIH SBIR phase I Grant
Industry Contract 2/1/2012 – 6/30/2012
(PI: Slaughter, Giridharan) $115,200
Syncardia
Syncardia hemolysis study
Industry Contract 3/1/2011 – 12/31/2011
(PI: Slaughter, Koenig) $83,841
Mark S. Slaughter, M.D. November 15, 2016
28
Thoratec (Pleasanton, CA)
MCS Device Testing
2R44HL092700-02 (Bosecker) 8/1/2010 –7/31/2012
(co-PIs: Slaughter, Koenig) $1,220,918
NIH-SBIR - Phase II Grant
Intraventricular cardiac assist system for recovery
R43 HL103014-01A1 3/1/2010 –2/28/2011
(PI: Slaughter, Koenig) $413,922
NIH SBIR phase I Grant
Feasibility Testing of Longhorn MVAD
R43HL102981 3/1/2010 –2/28/2011
(PI: Slaughter, Koenig) $244,850
NIH SBIR phase I Grant
Subcutaneous ECG sensing
Industry Contract 8/1/2010 –12/31/2011
(PI: Slaughter, Koenig) $107,411
Abiomed (Danvers, MA)
Symphony Study – GLP Supplement
R43HL102981 3/1/2010 –2/28/2011
(PI: Slaughter & Koenig) $244,850
NIH SBIR phase I Grant
Subcutaneous ECG sensing
Industry Contract 4/1/2010 –12/31/2010
(PI: Slaughter, Koenig) $177,254
Abiomed (Danvers, MA)
Impella 2.5 GLP Study
Industry Contract 8/1/2010 –12/31/2011
(PI: Slaughter, Koenig) $393,116
Abiomed (Danvers, MA)
Symphony Graft Testing Study
Industry Contract 10/1/2009 – 6/30/2012
(PI: Slaughter, Koenig) $206,000
HeartWare (Miami Lakes, FL)
MCS Device Testing
2R44HL088760-02 4/1/2009–3/31/2012
(PI: Slaughter, Koenig) $1,580,486
Mark S. Slaughter, M.D. November 15, 2016
29
NIH-SBIR - Phase II Grant
Portable pneumatic driver for counterpulsation therapy
2R44HL083586-02A1 1/2008–7/31/2011
(PI: Slaughter, Koenig) $1,440,170
NIH-SBIR Phase II Grant
Development of a Counterpulsation Therapy Device
KSTC-184-512-08-054 10/1/2008 –4/30/2010
(PI: Slaughter, Koenig) $500,000
Kentucky Science and Technology Corporation (KSTC) Grant
Implantable Sensing and Triggering System
Industry Contract 9/1/2008 –12/31/2010
(PI: Slaughter) $358,123
HeartWare (Miramar, FL)
MCS Device Chronic Testing Study
Industry Contract 9/1/2008 –12/31/2009
(PI: Slaughter) $148,827
HeartWare (Miramar, FL)
MCS Device Acute Testing Study
1R43HL088760-01 8/1/2007 –7/31/2008
(Slaughter / Consultant) $268,790
NIH-SBIR - Phase I (UofL subcontract)
Portable pneumatic driver for counterpulsation therapy
Industry Contract 4/1/2007 –3/31/2008
(PI: Slaughter) $50,000
Thoratec Corp
Testing flow estimator
1R43HL083586-01 6/1/2006 –1/31/2007
(Slaughter / Consultant) $172,749
NIH-SBIR Phase I (UofL subcontract)
A counterpulsation device to promote myocardial recovery
KSTC-02-DCIS-021 3/1/2007-12/31/2007
(Slaughter/Consultant) $100,000
Kentucky Science and Technology Corp
Counterpulsation device to promote myocardial recovery
Pathophysiologic Benefits 2005
of Continuous and Pulsatile Ventricular Assist $15,000
(Slaughter / PI)
Thoratec Corporation
Mark S. Slaughter, M.D. November 15, 2016
30
Comparison of Epicardial Blood 2003
(PI: Slaughter) $20,000
Flow during LVAD Support
Thoratec Corporation
Comparison of Epicardial Blood 2003
(PI: Slaughter) $10,000
Flow during LVAD Support
Effects of Exercise and Unloading 2001
by LVAD on Myofilament $40,000
Activation in Heart Failure
(Slaughter / Co-Investigator)
Foundation of Physical Therapy
Suppression of the Systemic 2000
Inflammatory Response of $30,000
Cardiopulmonary Bypass
(Slaughter / PI)
Medical Research Fund Christ Hospital
The Use of Leukine to Stimulate 1998-1999
Healing of Leg Wounds after $20,000
Coronary Artery Bypass Graft Surgery,
(Slaughter / Co-Investigator)
Immunex Corporation
Books/Book Chapters:
1. Black MC, Schumer EM, Trivedi JR, Slaughter MS. Recent Advances in Circulatory
Assist Devices. Handbook of Coronary Artery Disease
2. Slaughter MS. A companion to Baunwald’s Heart Disease; Mechanical Circulatory
Support. – Chapter 11: Surgical Methods in Circulatory Support. 2012; pages 141-152.
3. Slaughter MS. Ventricular Assist Devices for Destination Therapy. Atlas of Surgical
Treatment for Advanced Heart Failure. (In Press).
4. Sobieski MA, Giridharan G, Koenig SC, Slaughter MS. Counterpulsation Devices for
Myocardial Support. Cardiothoracic Surgery Review, edited by Franco: 2011 Ch 156,
pages 708-714.
5. Williams ML, Sobieski MA, Giridharan G, Koenig SC, Slaughter MS. Rotary and
Centrifugal Blood Pumps. Cardiothoracic Surgery Review, edited by Franco; 2011, Ch
149: Pages 666-675
Mark S. Slaughter, M.D. November 15, 2016
31
6. Birks E, Slaughter MS. Oxford Textbook of Heart Failure. – Chapter 51: Ventricular
Assist Devices, including Intra-Aortic Balloon Pumps. 51(537-546):2011. New York,
NY, Oxford University.
7. Implants for Surgery – Active implantable medical devices – Part 5: Circulatory Support
Devices. © 2010. Association for the Advancement of Medical Instrumentation.
ANSI/AAMI/ISO 14708-5:2010.
8. Slaughter MS. Cardiac Surgery in Chronic Renal Failure: Patient Management and
Clinical Outcomes. © 2007 Blackwell Publishing Ltd., Oxford, UK.
9. Slaughter MS, Deng M. Mechanical Circulatory Support: Chapter 10. Permanent
Mechanical Circulatory Support. ISHLT Monograph Series 2006.
10. Slaughter MS, Ward HB. Surgical Management of Heart Failure. Clinics in Geriatric
Medicine, Philadelphia, PA. WB Saunders Company, 16(3); 567-92, 2000.
Publications: (H index: 41)
1. Aronson KD, Silvestry SC, Maltais S, Mallidi HR, Frazier OH, Boyce SW, Leadley
K, Najarian KB, Slaughter MS, Pagani FD. Patients Awaiting Heart Transplantation
on HVAD Support for Greater than 2 Years. ASAIO J. 2016 Jul-Aug; 62(4):384-9.
doi: 10.1097/MAT. PMID: 27111739.
2. Cheng A, Schumer EM, Trivedi JR, Van Berkel VH, Massey HT, Slaughter MS.
Does Donor Cardiopulmonary Resusitationi Time Affect Heart Transplantation
Outcomes and Survival? Ann Thorac Surg. 2016 May 10. pii: S0003-4975(16)00218-
6. doi: 10.1016/j.arthoracsur.2016.02.034 [Epub ahead of print] PMID: 27173071
3. Schumer EM, Chaney JH, Trivedi JR, Linsky PL, Williams ML, Slaughter MS.
Emergency Coronary Bypass Grafting: Indications and Outcomes from 2003 through
2013. Tex Heart Inst J. 2016 Jun 1;43(3):214-9. doi: 10.14503/THIJ-14-4978.
eCollection 2016 Jun. PMID: 27303236.
4. Trivedi JR, Rajagopal K, Schumer EM, Birks EJ, Lenneman A, Cheng A, Slaughter
MS. Differences in Status 1A Heart Transplantation Survival in the Continuous Flow
Left Ventricular Assist Device Era. Ann Thorac Surg. 2016 Jun 18. pii: S0003-
4975(16)30354-X. doi: 10. 1016/j.arthoracsur.2016.04.027 [Epub ahead of print]
PMID: 27329191
5. Weerahandi H, Goldstein N, Gelfman LP, Jorde U, Kirpatrick JN, Marble J, Naka Y,
Pinney S, Slaughter MS, Bagiella E, Ascheim DD. Pain and Functional Status in
Mark S. Slaughter, M.D. November 15, 2016
32
Patients with Ventricular Assist Devices. J Pain Symptom Manage. 2016 Jul 8. pii:
S0885-3924(16)30181-6. doi: 10.1016/j.jpainsymman.2016.05016. [Epub ahead of
print] PMID: 27401516
6. Mondal NK, Roychoudhury S, Mukherjee S, Siddique S, Banerjee M, Slaughter MS,
Lahiri T, Ray MR. Increased Risk of Cardiovascular Disease in Premenopausal
Female Ragpickers of Eastern India: Involvement of Inflammation, Oxidative Stress
and Platelet Hyperactivity. Mol Cell Biochem. 2016 Aug;419 (1-2):193-203. doi:
10.1007/s11010-016-2773-3. Epub 2016 Jul 15. PMID:27421852.
7. Cowger JA, Castle L, Aaronson K, Slaughter MS, Moainie S, Walsh M, Salerno C.
ASAIO J. 2016 Mar 7. The HeartMate II Risk Score: An Adjusted Score for
evaluation of all continuous flow left assist devices. PMID:26955002
8. Black MC, Slaughter MS.Proactive or reactive? Best approach to limb ischemia in
peripheral venoarterial extracorporeal life support. J Thorac Cardiovasc Surg. 2015
Dec 13. pii: S0022-5223(15)02395-8. doi: 10.1016/j.jtcvs.2015.11.064.
PMID:26778380
9. Trivedi JR, Cheng A, Ising M, Lenneman A, Birks E, Slaughter MS.
10. ASAIO J. 2016 Jan 13. Heart Transplant Survival Based on Recipient and Donor
Risk Scoring: a UNOS Database Analysis . PMID:26771395
11. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Myers S, Acker MA, Rogers J,
Slaughter MS, Stevenson LW. Pump Thrombosis in the Thoratec HeartMate II
Device: An Update Analysis of the INTERMACS Registry. J Heart Lung Transplant
2015 Dec; 34(12):1515-26. doi: 10.1016/j.healun.2015.10.024.
12. Chen Z, Mondal NK, Ding J, Koenig, SC, Slaughter MS, Wu ZJ. Paradoxical Effect
of Nonphysiological Shear Stress on Platelets and von Willebrand Factor. Artif
Organs 2015 Nov 18. doi: 10.1111/aor.12606. [Epub ahead of print]
13. Schumer EM, Black MC, Monreal G, Slaughter MS. Left Ventricular Assist
Devices: Current Controversies and Future Directions. Eur Heart J 2015 Nov 4. pii:
ehv590. [Epub ahead of print]
14. Schumer EM, Ising MS, Slaughter MS. The Current State of Left Ventricular Assist
Devices: Challenges Facing Further Development. Expert Rev Cardiovasc Ther 2015
Nov; 13(11):1158-93. doi: 10.1586/14779072.2015. 1098534. Epub 2015 Nov 2.
15. Teuteberg JJ, Slaughter MS, Rogers JG, McGee EC, Pagani FD, Gordon R, Rame E,
Acker M, Kormos RL, Salerno C. Schleeter TP, Goldstein DJ, Shin J, Starling RC,
Wozniak T, Malik AS, Silvestry S, Ewald GA, Jorde UP, Naka Y, Birks E, Najarian
Mark S. Slaughter, M.D. November 15, 2016
33
KB, Hathaway DR, Aaronson KD; ADVANCE Trial Investigators. JACC Heart Fail
2015 Oct;3(10):818-28. doi: 10.1016/j.jchf.2015.05.011.
16. Mondal NK, Sorensen EN, Pham SM, Koenig SC, Griffith BP, Slaughter MS, Wu
ZJ. Systemic Inflammatory Response Syndrome in End-Stage Heart Failure Patients
Following Continuous-Flow Left Ventricular Assist Device Implantation: Differences
in Plasma Redox Status and Leukocyte Activation. Artif Organs 2015 Sept29. doi:
10.1111/aor. 12580 [Epub ahead of print]
17. Ising MS, Sobieski MA, Slaughter MS, Loenig SC, Giridharan GA. Feasibility of
Pump Speed Modulation for Restoring Vascular Pulsatility with Rotary Blood
Pumps. ASAIO J. 2015 Sept-Oct; 61(5):526-32. doi: 10.1097.
18. Bhatia N, Voelkel AJ, Hussain Z, Sharma UC, Slaughter MS, Birks EJ, McCants
KC. Safety and Feasibility of Induction Immunosuppression When Driveline
Infection Is an Indication for Cardiac Transplantation. Thorac Cardiovasc Surg. 2015
Dec; 63(8):675-83. doi: 10.1055/s-0035-1564449. Epub 2015 Sep 14.
19. Schumer EM, Ising MS, Trivedi JR, Slaughter MS, Cheng A. Early Outcomes with
Marginal Donor Hearts Compared with Left Ventricular Assist Device Support in
Patients with Advanced Heart Failure. Ann Thorac Surg. 2015 Aug:100(2):522-7.
doi: 10.1016/j. athoracsur.2015.02.089.Epub 2015 Jun 9.
20. Chen Z, Mondal NK, Ding J, Koenig SC, Slaughter MS, Griffith BP, Wu ZJ.
Activation and Shedding of Platelet Glycoprotein IIB/IIIa Under Non-physiological
Shear Stress. Mol Cell Biochem. 2015 Nov; 409 (1-2): 93-101. doi: 10.1007/211010-
015-2515-y. Epub 2015 Jul 10.
21. Schumer EM, Zoeller KA, Linsky PL, Monreal G, Choi Y, Giridharan GA, Sobieski
MA, Slaughter MS, van Berkel VH. Feasibility Study of Pulsatile Left Ventricular
Assist Device for Prolonged Ex Vivo Lung Perfusion. Ann Thorac Surg. 2015
Jun;99(6):1961-8. doi: 10.1016/j.athoracsur.2015.02.087. Epub 2015 Apr 25.
22. Huang J, Donneyong M, Trivedi J, Barnard A, Chaney J, Dotson A, Raymer S,
Cheng A, Liu H, Slaughter MS. Preoperative Aspirin Use and Its Effect on Adverse
Events in Patients Undergoing Cardiac Operations. Ann Thorac Surg. 2015
Jun;99(6):1975-81. doi: 10.1016/j.athoracsur.2015.02.032. Epub 2015 Apr 23.
23. Birks EJ, McGee EC, Aaronson KD, Boyce S, Cotts WG, Naijar SS, Pagani FD,
Hathaway DR, Najarian K, Jacoski MV, Slaughter MS, ADVANCE Trial
Investigators. An Examination of Survival by Sex and Race in the HeartWare
Ventricular Assist Device for the Treatment of Advanced Heart Failure (ADVANCE)
Bridge to Transplant (BTT) and Continued Access Protocol Trials. J Heart Lung
Transplant 2015 Jun;34(6):815-24. doi: 10.1016/j.healun.2014.12.011. Epub 2014
Mark S. Slaughter, M.D. November 15, 2016
34
Dec 29.
24. Goldstein DJ, Aaronson KD, Tatooles AJ, Silvestry SC, Jeevanandam V, Gordon R,
Hathaway DR, Najarian KB, Slaughter MS, ADVANCE Investigators.
Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System.
JACC Heart Fail. 2015 Apr;3(4):303-13. doi: 10.1016/j.jchf.2014.11.008. Epub 2015
Mar 11.
25. Slaughter MS. Chronic implantable mechanical circulatory support 50 years later:
still shooting for the stars! Ann Thorac Surg. 2015 Mar;99(3):749-51. doi:
10.1016/j.athoracsur.2015.01.016.
26. Nielsen VG, Sobieski MA 2nd, Slaughter MS. Left Ventricular Assist Device
Associated Carbon Monoxide and Iron Enhanced Hypercoagulation: Impact of
Concurrent Disease. ASAIO J. 2015 Feb 13. [Epub ahead of print]
27. Rogers JG, Boyle AJ, O'Connell JB, Horstmanshof DA, Haas DC, Slaughter MS,
Park SJ, Farrar DJ, Starling RC. Risk assessment and comparative effectiveness of
left ventricular assist device and medical management in ambulatory heart failure
patients: design and rationale of the ROADMAP clinical trial. Am Heart J 2015 Feb;
169(2): 205-210 e20 doi: 10.1016/j.ahj.2014.11.004. Epub 2014 Nov 11.
28. Giridharan GA, Koenig SC, Soucy KG, Choi Y, Pirbodaghi T, Bartoli CR, Monreal
G, Sobieski MA, Schumer E, Cheng A, Slaughter MS. Left ventricular volume
unloading with axial and centrifugal rotary blood pumps. ASAIO J. 2015 May-
Jun;61(3):292-300. doi: 10.1097.
29. Giridharan GA, Koenig SC, Soucy KG, Choi Y, Pirbodaghi T, Bartoli CR, Monreal
G, Sobieski MA, Schumer E, Cheng A, Slaughter MS. Hemodynamic Changes and
Retrograde Flow in LVAD Failure. ASAIO J. 2015 May-Jun;61(3):282-91. doi:
10.1097.
30. Karkouti K, Grocott HP, Hall R, Jessen ME, Kruger C, Lerner AB, MacAdams C,
Mazer CD, de Medicis É, Myles P, Ralley F, Rheault MR, Rochon A, Slaughter MS,
Sternlicht A, Syed S, Waters T. Interrelationship of preoperative anemia,
intraoperative anemia, and red blood cell transfusion as potentially modifiable risk
factors for acute kidney injury in cardiac surgery: a historical multicentre cohort
study. Can J Anaesth. 2015 Apr;62(4):377-84. doi: 10.1007/s12630-014-0302-y.
Epub 2014 Dec 24.
31. Gopinathannair R, Birks EJ, Trivedi JR, McCants KC, Sutton BS, Deam AG,
Slaughter MS, Hottigoudar RU. Impact of cardiac resynchronization therapy on
Mark S. Slaughter, M.D. November 15, 2016
35
clinical outcomes in patients with continuous-flow left ventricular assist devices. J
Card Fail. 2015 Mar;21(3):226-32. doi: 10.1016/j.cardfail.2014.12.006. Epub 2014
Dec 17.
32. Cheng A, Williamitis CA, Slaughter MS. Comparison of continuous-flow and
pulsatile-flow left ventricular assist devices: is there an advantage to pulsatility? Ann
Cardiothorac Surg. 2014 Nov;3(6):573-81. doi: 10.3978/j.issn.2225-
319X.2014.08.24.
33. Soucy KG, Giridharan GA, Choi Y, Sobieski MA, Monreal G, Cheng A, Schumer E,
Slaughter MS, Koenig SC. Rotary pump speed modulation for generating pulsatile
flow and phasic left ventricular volume unloading in a bovine model of chronic
ischemic heart failure. J Heart Lung Transplant. 2015 Jan;34(1):122-31. doi:
10.1016/j.healun.2014.09.017. Epub 2014 Sep
34. Soucy KG, Smith EF, Monreal G, Rokosh G, Keller BB, Yuan F, Matheny RG,
Fallon AM, Lewis BC, Sherwood LC, Sobieski MA, Giridharan GA, Koenig SC,
Slaughter MS. Feasibility study of particulate extracellular matrix (P-ECM) and left
ventricular assist device (HVAD) therapy in chronic ischemic heart failure bovine
model. ASAIO J. 2015 Mar-Apr;61(2):161-9. doi: 10.1097.
35. Schumer E, Monreal G, Carnahan S, et al. Outcomes for heart transplantation in
patients older than 64. J Ky Med Association.* Oct 2014; 112(10): 221-225.
36. Wang Y, Koenig S, Slaughter M, Giridharan G. Suction prevention and physiologic
control of continuouse flow left ventricular assist devices using intrinsic pump
parameters. ASAIO J. 2014 Nov 13.
PMID 25396276.
37. Abraham WE, Aggarwal S, Prabhu SD, Cecere R, Pamboukian SV, Bank AJ, Sun B,
Pae WE Jr, Hayward CS, McCarthy PM, Peters WS, Verta P, Slaughter MS; C-Pulse
Trial Study Groupd. Ambulatory extra-aortic Counterpulsation in patients with
moderate to severe chronic heart failure. JACC Heart Fail. 2014 Oct;2(5):526-33.
Doi: 10.1016/j.jchf.2014.04.014
PMID 25301151.
38. Wang Y, Koenig S, Slaughter M, Giridharan G. Rotary blood pump control strategy
for preventing left ventricular suction. ASAIO J. 2014 Sept. 22
PMID: 25248043
39. Koenig SC, Jimenez JH, West SD, Sobieski MA, Choi Y, Monreal G, Giridharah GA,
Soucy KG, Slaughter MS. Early feasibility testing and engineering development of a
sutureless beating heart connector for left ventricular assist devices. ASAIO J. 2014
Nove-Dec;60(6):317-25. doi: 10.1097.
Mark S. Slaughter, M.D. November 15, 2016
36
PMID: 25238500.
40. Wieselthaler GM, Slaughter M. Artif Organs Welcome to ISRBP 2014. 2014
Sep;38(9): 725-6. Doi: 10.1111/aor.12405. No abstract available.
PMID 25234755.
41. Slaughter MS, Soucy KG, Matheny RG, Lewis BC, Hennick MF, Choi Y, Monreal
G, Sobieski MA, Giridharan GA, Koenig SC. Development of an extracellular matrix
delivery system for effective intramyocardial injection in ischemic tissue. ASAIO J.
2014 Nov-Dec;60(6):730-6. Doi: 10.1097.
PMID 25232775.
42. Cheng A, Monreal G, William ML, Sobieski M 2nd, Slaughter MS. Extended extra-
aortic Counterpulsation with the C-pulse device does not alter aortic wall structure.
ASAIO J. 2014 Nov-Dec;60(6):e5-7. Doi: 10.1097.
PMID: 25158886.
43. Cheng A, Slaughter MS. J Thorac Dis. 2014 Aug; 6(8):1105-9. Doi:
10.3978/j.issn.2072-1439.2014.07.37. Heart Transplantation.
PMID: 25132977. *KMA Journal not listed in Pubmed
44. Trivedi JR, Cheng A, Singh R, Williams ML, Slaughter MS; Survival on the heart
transplant waiting list; impact of continuous flow left ventricular assist device as
bridge to implant. Ann Thorac Surg. 2014 Sept;98(3):830-4. Doi:
10.1016/j.athoracsur.2014.05.019. Epub 2014 july 31.
PMID 25087934
45. John R, Aaronson KD, Pae WE, Ackere MA, Hathaway DR, Najarian KB, Slaughter
MS; HeartWare Bridge to Transplant ADVANCE Trial Investigators. Drive Line
Infections and sepsis in patients receiving the HVAD system as a left ventricular
assist device. J Heart Lung Transplant. 2014 Oct; 33(10): 1066-73. Doi:
10.4016/j.healun.2014.05.010. Epub 2014 Jun 4.
PMID: 25087103.
46. Linsky PL, Choi Y, Ouseph R, Slaughter MS, Keller BB, Jones CM. High
Resolution Imaging using the VisualSonics Vevo 2100 on Isolated, Perfused Procine
Kidneys on mechanical Circulatory Support
ASAIO J. 2014 May 8 (Epub ahead of print)
PMID: 24814832.
47. Linsky PL, Slaughter MS. Bud Frazier’s 1000th Implantation of a Ventricular Assist
Device. Tex Heart Inst J. 2014 Apr 1;41(2):110-1. doi: 10.14503/THIJ-14-4113.
Mark S. Slaughter, M.D. November 15, 2016
37
eCollection 2014. PMID: 24808765.
48. Brisco MA, Sundareswaran KS, Milano CA, Feldman D, Testani JM, Ewald GA,
Slaughter MS, Farrar DJ, Goldberg LR. The Incidence, Risk, and Consequences of
Atrial Arrhythmias in Patients with Continuous-Flow Left Ventricular Assist Devices.
J Card Surg. 2014 Apr 18.
49. Donneyong M, Cheng A, Trivedi JR, Schumer E, McCants KC, Birks EJ, Slaughter
MS. The Association of Pre-Transplant HeartMate II Left Ventricular Assist Device
Placement and Heart Transplantation Mortality. ASAIO J. 2014 Mar 7.
50. Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof DA,
Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ; HeartmATE
ii Clinical Investigators. “Results of the Destination Therapy Post-FDA-Approval
Study with a Continuous Flow Left Ventricular Assist Device: A Prospective Study
Using the INTERMACS Registry.J Am Coll Cardiol. 2014 Feb 21.
51. Giridharan GA, Koenig SC, Slaughter MS. “Do Axial –Flow LVADs Unload Better
than Centrifugal-Flow LVADs? ASAIO J. 2014 Mar-Apr.
52. Shah KB, Kwakkel-van Erp JM, Migliore C, Orr Y, Corris PA, Glanville AR,
Slaughter MS, West
LJ, Mehra MR. “Scientific progress in heart and lung failure, mechanical circulatory
support, and transplantation: Highlights from the Journal of Heart and Lung
Transplantation.” J Heart Lung Transplant. 2013 Dec 4.
53. Slaughter MS. “O.H. “Bud” Frazier, M.D. Mechanical Circulatory Support Pioneer”.
Texas Heart Institute Journal. Jan 29, 2014.
54. Najjar SS, Slaughter, MS, Pagani FD, Starling RC, McGee EC, Eckman P, Tatooles
AJ, Moazami N, Kormos RL, Hathaway DR, Najarian KB, Bhat G, Aaronson KD,
Boyce SW. HVAD Bridge to Transplant ADVANCE Trial Investigators. “An
analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to
transplant and continued access protocol trial”. J Heart Lung Transplant. 2014 Jan.
55. Tamez D, Larose JA, Shambaugh C, Chorpenning K, Soucy KG, Sobieski MA,
Sherwood L, Giridharan GA, Monreal G, Koenig SC, Slaughter MS. “Early
Feasibility Testing and Engineering Development of the Transapical Approach for the
HeartWare MVAD Ventricular Assist System.” ASAIO J. 2014 Jan 22.
56. Slaughter MS. “Shaping the Future!” ASAIO J. 2014 Jan-Feb.
57. Monreal G, Sherwood LC, Sobieski MA, Giridharan GA, Slaughter MS, Koenig SC.
“Large Animal Models for Left Ventricular Assist Device Research and
Development”. ASAIO J. 2014 Jan-Feb.
Mark S. Slaughter, M.D. November 15, 2016
38
58. Slaughter MS. Long-Term Mechanical Circulatory Support for Advanced Heart
Failure: “The Tide is Turning”. Eur J Heart Fail. 2013 Oct.
59. Williams ML, He X, Rankin JS, Slaughter MS, Gammie JS. Preoperative Hematocrit
is a Powerful Predictor of Adverse Outcomes in Coronary Artery Bypass Graft
Surgery: A Report From The Society of Thoracic Surgeons Adult Cardiac Surgery
Database. Ann Thorac Surg. 2013 Sep 19.
60. Cheng A, Slaughter MS. How I Choose Conduits and Configure Grafts for my
Patients-Rationales and Practices. Ann Cardiothoracic Surg. 2013 Jul.
61. Pagni S, Ganzel BL, Trivedi JR, Singh R, Mascio CE, Austin EH, Slaughter MS,
Williams ML. Early and Midterm Outcomes Following Surgery for Acute Type A
Aortic Dissection. J Card Surg. 2013 Aug 2.
62. Bartoli CR, Sherwood LC, Giridharan GA, Slaughter MS, Wead WB, Prabhu SD,
Koenig SC. Bovine Model of Chronic Ischemic Cardiomyopathy: Implications for
Ventricular Assist Device Research. Artif Organs. 2013 Jul 22.
63. Hottigoudar RU, Deam AG, Birks EJ, McCants KC, Slaughter MS, Gopinathannair
R. Catheter ablation of atrial flutter in patients with left ventricular assist device
improves symptoms of right heart failure. Congest Heart Fail. 2013 Jul.
64. Soucy KG, Koenig SC, Sobieski MA, Slaughter MS, Giridharan GA. Fault detection
in rotary blood pumps using motor speed response. ASAIO J. 2013 Jul-Aug.
65. Trivedi JR, Sobieski MA, Schwartz S, Williams ML, Slaughter MS. Novel
thrombosis risk index as predictor of left ventricular assist device thrombosis. ASAIO
J. 2013 Jul-Aug.
66. Soucy KG, Koenig SC, Giridharan GA, Sobieski MA, Slaughter MS. Rotary pumps
and diminished pulsatility: do we need a pulse? ASAIO J. 2013 Jul-Aug.
67. Slaughter MS, Pagani FD, McGee EC, Birks EJ, Cotts WG, Gregoric I, Howard
Frazier O, Icenogle T, Najjar SS, Boyce SW, Acker MA, John R, Hathaway DR,
Najarian KB, Aaronson KD; HeartWare Bridge to Transplant ADVANCE Trial
Investigators. HeartWare ventricular assist system for bridge to transplant: Combined
results of the bridge to transplant and continued access protocol trial. J Heart Lung
Transplant. 2013 Jul.
68. Ising M, Koenig S, Sobieski M, Slaughter M, Giridharan G. “Flow Modulation
Algorithms for Intra-Aortic Rotary Blood Pumps to Reduce Coronary Steal.” 2011
Biomedical Engineering Society Annual Meeting, Hartford, CT, October 12 – 15,
2011.
Mark S. Slaughter, M.D. November 15, 2016
39
69. Sherwood LC, Sobieski MA, Koenig SC, Giridharan GA, Slaughter MS. Benefits of
aggressive medical management in a bovine model of chronic ischemic heart failure.
ASAIO J. 2013 May-Jun.
70. Rumsfeld JS, Alexander KP, Goff DC Jr, Graham MM, Ho PM, Masoudi FA, Moser
DK, Roger VL, Slaughter MS, Smolderen KG, Spertus JA, Sullivan MD, Treat-
Jacobson D, Zerwic JJ; American Heart Association Council on Quality of Care and
Outcomes Research, Council on Cardiovascular and Stroke Nursing, Council on
Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Stroke
Council. Cardiovascular health: the importance of measuring patient-reported health
status: a scientific statement from the American Heart Association. Circulation. 2013
Jun 4.
71. Dassanayaka S, Slaughter MS, Bartoli CR. Mechanistic pathway(s) of acquired von
willebrand syndrome with a continuous-flow ventricular assist device: in vitro
findings. ASAIO J. 2013 Mar-Apr.
72. Soucy KG, Koenig SC, Giridharan GA, Sobiesku, MA, Slaughter MS. Defining
pulsatility during continuous-flow ventricular assist device support. J Heart Lung
Transplant. 2013 Mar 26.
73. Bartoli CR, McCants KC, Birks EJ, Flaherty MP, Slaughter MS. Percutaneous
closure of a patent foramen ovale to prevent paradoxical thromboembolism in a
patient with a continuous-flow LVAD. J Invasive Cardiol. 2013 Mar.
74. Gordon RJ, Weinberg AD, Pagani FD, Slaughter MS, Pappas PS, Naka Y, Goldstein
DJ, Dembitsky WP, Giacalone JC, Ferrante J, Ascheim DD, Moskowitz AJ, Rose
EA, Gelijns AC, Lowy FD. Prospective, multicenter study of ventricular assist device
infections. Circulation. 2013 Feb 12.
75. Cowger J, Sundareswaran K, Rogers JG, Park SJ, Pagani FD, Bhat G, Jaski B, Farrar
DJ, Slaughter MS. Predicting Survival in Patients Receiving Continuous Flow Left
Ventricular Assist Devices: The HeartMate II Risk Score. J Am Coll Cardiol. 2013
Jan 22.
76. Moazami N, Milano CA, John R, Sun B, Adamson RM, Pagani FD, Smedira N,
Slaughter MS, Farrar DJ, Frazier OH; HeartMate II Investigators. Pump replacement
for left ventricular assist device failure can be done safely and is associated with low
mortality. Ann Thorac Surg. 2013 Feb.
77. Huang J, Slaughter MS. HeartWare ventricular assist device placement in a patient
with congenitally corrected transposition of the great arteries. J Thorac Cardiovasc
Surg. 2013 Feb.
78. Acker MA, Pagani FD, Stough WG, Mann DL, Jessup M, Kormos R, Slaughter MS,
Mark S. Slaughter, M.D. November 15, 2016
40
Baldwin T, Stevenson L, Aaronson KD, Miller L, Naftel D, Yancy C, Rogers J,
Teuteberg J, Starling RC, Griffith B, Boyce S, Westaby S, Blume E, Wearden P,
Higgins R, Mack M. Statement regarding the pre and post market assessment of
durable, implantable ventricular assist devices in the United States. J Heart Lung
Transplant. 2012 Dec.
79. Emani S, Brewer RJ, John R, Slaughter MS, Lanfear DE, Ravi Y, Sundareswaran
KS, Farrar DJ, Sai-Sudhakar CB. Patients with low compared with high body mass
index gain more weight after implantation of a continuous-flow left ventricular assist
device. J Heart Lung Transplant. 2013 Jan.
80. Acker MA, Pagani FD, Stough WG, Mann DL, Jessup M, Kormos R, Slaughter MS,
Baldwin T, Stevenson L, Aaronson KD, Miller L, Naftel D, Yancy C, Rogers J,
Teuteberg J, Starling RC, Griffith B, Boyce S, Westaby S, Blume E, Wearden P,
Higgins R, Mack M. Statement regarding the pre and post market assessment of
durable, implantable ventricular assist devices in the United States. Ann Thorac Surg.
2012 Dec.
81. Acker MA, Pagani FD, Stough WG, Mann DL, Jessup M, Kormos R, Slaughter MS,
Baldwin T, Stevenson L, Aaronson KD, Miller L, Naftel D, Yancy C, Rogers J,
Teuteberg J, Starling RC, Griffith B, Boyce S, Westaby S, Blume E, Wearden P,
Higgins R, Mack M. Statement regarding the pre and post market assessment of
durable, implantable ventricular assist devices in the United States: Executive
Summary. Ann Thorac Surg. 2012 Dec.
82. Acker MA, Pagani FD, Stough WG, Mann DL, Jessup M, Kormos R, Slaughter MS,
Baldwin T, Stevenson L, Aaronson KD, Miller L, Naftel D, Yancy C, Rogers J,
Teuteberg J, Starling RC, Griffith B, Boyce S, Westaby S, Blume E, Wearden P,
Higgins R, Mack M. Statement regarding the pre and post market assessment of
durable, implantable ventricular assist devices in the United States. Circ Heart Fail.
2013 Jan 1.
83. Acker MA, Pagani FD, Stough WG, Mann DL, Jessup M, Kormos R, Slaughter MS,
Baldwin T, Stevenson L, Aaronson KD, Miller L, Naftel D, Yancy C, Rogers J,
Teuteberg J, Starling RC, Griffith B, Boyce S, Westaby S, Blume E, Wearden P,
Higgins R, Mack M. Statement regarding the pre and post market assessment of
durable, implantable ventricular assist devices in the United States: Executive
Summary. Circ Heart Fail. 2013 Jan 1.
84. Slaughter MS, Singh R. The Role of Ventricular Assist Devices in Advanced Heart
Failure. Rev Esp Cardiol. 2012 Nov.
85. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, Pappas P,
Tatooles A, Stoddard MF, Lima JA, Slaughter MS, Anversa P, Bolli R.
Mark S. Slaughter, M.D. November 15, 2016
41
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the
SCIPIO trial: surgical aspects and interim analysis of myocardial function and
viability by magnetic resonance. Circulation. 2012 Sep 11.
86. Giridharan GA, Lee TJ, Ising M, Sobieski MA, Koenig SC, Gray LA, Slaughter MS.
Miniaturization of mechanical circulatory support systems. Artif Organs. 2012 Aug.
87. Sobieski MA, Giridharan GA, Ising M, Koenig SC, Slaughter MS. Blood Trauma
Testing of CentriMag and RotaFlow Centrifugal Flow Devices: A Pilot Study. Artif
Organs. 2012 Aug.
88. Slaughter MS. Summary of the 19th congress of the international society for rotary
blood pumps. Artif Organs. 2012 Aug.
89. Sayfo S, Stepp LO, Ganzel B, Slaughter MS, Flaherty MP. Management of
Recurrent Leaks Following Postinfarction Ventricular Septal Defect Repairs. J Card
Surg. 2012 Aug 13.
90. Giridharan GA, Cheng RC, Glower JS, Ewert DL, Sobieski MA, Slaughter MS,
Koenig SC. Control strategies for afterload reduction with an artificial vasculature
device. ASAIO J. 2012 Jul.
91. Slater AD, Tatooles AJ, Coffey A, Pappas PS, Bresticker M, Greason K, Slaughter
MS. Prospective clinical study of a novel left atrial appendage occlusion device. Ann
Thorac Surg. 2012 Jun.
92. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, Jessup
ML,
Gregoric ID, Loyalka P, Frazier OH, Jeevanandam V, Anderson AS, Kormos RL,
Teuteberg JJ, Levy WC, Naftel DC, Bittman RM, Pagani FD, Hathaway DR, Boyce
SW; for the HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant
ADVANCE Trial Investigators. Use of an Intrapericardial, Continuous-Flow,
Centrifugal Pump in Patients Awaiting Heart Transplantation. Circulation. 2012 Jun
26.
93. Gordon RJ, Miragaia M, Weinberg AD, Lee CJ, Rolo J, Giacalone JC, Slaughter
MS, Pappas P, Naka Y, Tector AJ, de Lencastre H, Lowy FD. Staphylococcus
epidermidis colonization is highly clonal across US cardiac centers. J Infect Dis. 2012
May 1.
94. Slaughter MS, Rogers JG. Editorial Commentary: Determining the cost-
effectiveness of mechanical circulatory support. J Heart Lung Transplant 2012 May.
95. Cannon RM, Trivedi JR, Pagni S, Dwivedi A, Bland JN, Slaughter MS, Ross CB,
Richardson JD, Williams ML. Open repair of blunt thoracic aortic injury remains
relevant in the endovascular era. J Am Coll Surg. 2012 Jun.
Mark S. Slaughter, M.D. November 15, 2016
42
96. Williams ML, Ganzel BL, Slater AD, Slaughter MS, Trivedi JR, Edmonds HL,
Pagni S, Antegrade Versus Retrograde Cerebral Protection in Repair of Acute
Ascending Aortic Dissection. Amer Surg. 2012 Mar.
97. Slaughter MS. Invited Commentary. Ann of Thor Surg. 2012 Mar.
98. Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, Ewald
GA, Sundareswaran KS, Farrar DJ, Slaughter MS. Outcomes in advanced heart
failure patients with left ventricular assist devices for destination therapy. Circulation
Heart Fail. 2012 Mar 1.
99. Petrucci RJ, Rogers JG, Blue L, Gallagher C, Russell SD, Dordunno D, Jaski BE,
Chillcott S, Sun B, Yanssen TL, Tatooles A, Koundakjian L, Farrar DJ, Slaughter
MS. Neurocognitive function in destination therapy patients receiving continuous-
flow vs pulsatile-flow left ventricular assist device support. J Heart Lung Transplant.
2012 Jan.
100. *Rogers JG, Bostic RR, Tong KB, Adamson R, Russo M, Slaughter MS. Cost-
effectiveness analysis of continuous-flow left ventricular assist devices as destination
therapy. Circ Heart Fail. 2012 Jan.
*Circulation: Heart Failure Editors' Picks: Most Important Articles Published in
2012
101. Slaughter, MS. Implantation of the HeartWare Left Ventricular Assist Device.
Semin Thoracic Cardiovasc Surg. 2011 Autumn.
102. Slaughter MS. Invited Commentary. Ann Thorac Surg. 2011 Dec.
103. Giridharan GA, Lederer C, Berthe A, Goubergrits L, Hutzenlaub J, Slaughter MS,
Dowling RD, Spence PA, Koenig SC. Flow dyanmics of a novel counterpulsation
device characterized by CFD and PIV modeling. Medical Engineering & Physics
(Epub ahead of print June 2011) 2011 Dec.
104. Slaughter MS. UNOS Status of Heart Transplant Patients Supported with a Left
Ventricular Assist Device: Is It Time to Reconsider the Status Criteria? Tex Heart
Inst J. 2011.
105. Hottigoudar RU, Deam AG, Slaughter MS, Sutton BS, McCants K, Birks E,
Gopinathannair R. Ventricular Tachycardia Ablation in Patients with HeartMate II Left
Ventricular Assist Devices: Rhythm Still Matters in Bionic Age. J of Innov Cardiac
Rhythm Mgmt. 2011 November.
Mark S. Slaughter, M.D. November 15, 2016
43
106. Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM,
Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D,
Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Cardiac
Stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a
randomized phase 1 trial. Lancet. 2011 Nov 26.
107. Joshi JK, Beache GM, Slaughter MS, Sobieski MA, Schneider W, Stoddard MF.
Coronary artery fistula: 64-Slice Computed Tomographic delineation and correlation
with Multiplane Trasnesophageal Echocardiography and Surgical findings.
Echocardiography. 2011 Nov 13.
108. Slater AD, Tatooles A, Coffee A, Pappas P, Bresticker M, Pagni S, Beckman D,
Wozniak T, Greason K, Ganzel B, Rousu A, Austgen C, Stoddard M, Slaughter MS.
Prospective Clinical Study of TigerPaw® Left Atrial Appendage Occlusion Device.
Ann Thorac Surg. 2012 Jun.
109. Meyer A, Slaughter M. The total artificial heart. Panminera Med. 2011 Sep.
110. Giridharan GA, Sobieski MA, Ising M, Slaughter MS, Koenig SC. Blood trauma
testing for mechanical circulatory support devices. Biomed Instrum Technol. 2011
Jul-Aug.
111. Chug AR, Loughran JH, Slaughter MS. Circadian variations in blood pressure in
health and disease: implications for patient management. Journal of
Chronophysiology and Therapy. 2011 Aug.
112. Slaughter MS. Implantation of the HeartWare Left Ventricular Assist Device.
Semin Thorac Cardiovasc Surg. 2011 Autumn.
113. Slaughter MS. Risk Assessment for Continuous Flow Left Ventricular Assist
Devices (LVAD): Does the Destination therapy Risk Score Work? An Analysis of
Over 600 Patients. J Am Coll Cardiol 2011.
114. Slaughter MS, Meyer AL, Birks EJ. Destination therapy with Left Ventricular
Assist Devices: Patient Selection and Outcomes. Current Opinion in Cardiology.
Curr Opin Cardiol 2011 May.
115. Meyer AL, Williams ML, Slaughter, MS. The percutaneous ventricular assist device
TandemHeart in severe efractory cardiogenic shock. Interv. Cardiol. (2011).
116. Slaughter MS, Bostic R, Tong K, Russo M, Rogers J. Temporal Changes in
Hospital Costs for Left Ventricular Assist Device Implantation. J Card Surg. 2011
Sep.
117. Williams ML, Trivedi JR, McCants KC, Prabhu SD, Birks EJ, Oliver L, Slaughter
MS. Heart Transplant Vs. Left Ventricular Assist Device (LVAD) In Heart
Mark S. Slaughter, M.D. November 15, 2016
44
Transplant Eligible Patients. Ann Thorac Surg. 2011 May.
118. Williams ML, Trivedi JR, Doughtie CA, Slaughter MS. Is Female Sex an
Independent Risk Factor for Perioperative Transfusion in Coronary Artery Bypass
Graft Surgery? J Am Coll Surg. 2011 Mar.
119. Hall JL, Fermin DR, Birks EJ, Barton PJ, Slaughter M, Eckman P, Baba HA,
Wohschlaeger J, Miller LW. Clinical, molecular and genomic changes in response to
a left ventricular assist device. J Am Coll Cardiol.2011 Feb 8.
120. Slaughter MS, Pederson B, Graham JD, Sobieski MA, Koenig SC. Evaluation of
new Forcefield Technology: Reducing platelet adhesion and cell coverage of
pyrolytic carbon surfaces. J thorac Cardiovasc Surg. 2011 Oct.
121. Slaughter MS, Giridharan GA, Tamez D, Larose J, Sobieski MA, Sherwood L,
Koenig SC. Transapical miniaturized ventricular assist device: Design and initial
testing. J Thorac Cardiovasc Surg. 2011 Sep.
122. Huang J, Slaughter, MS. Congenital Partial Absence of the Pericardium. The Annals
of Thoracic Surgery. Ann Thorac Surg. 2011 Feb. Cowger JA, Castle L, Aaronson
K, Slaughter MS, Moainie S, Walsh M, Salerno C.
123. Slaughter MS. Arterial conduits for surgical revascularization. Circulation. 2011
Sep 20.
124. Slaughter MS. Excellent outcomes with use of synthetic vascular grafts for
treatment of mycotic pseudoneurysms after heart transplantation. Ann Thorac Surg.
Invited Commentary accepted August 2011.
125. Huang J, Slaughter MS. Continuous aortic Regurgitation with Ventricular Assist
Device. Anesthesiology 2011 Aug.
126. Slaughter MS, Sobieski MA, Graham JD, Pappas PS, Tatooles AJ, Koenig SC.
Platelet Activation in Heart Failure Patients Supported by the HeartMate II
Ventricular Assist Device. Int J Artif Organs. 2011 Jun.
127. Tueteberg J, Rogers JG, Park SJ, Ewald GA, Tatooles AJ, Lietz K, Miller LW,
Kormos RL, Sundareswaran KS, Farrar DJ, Sla
128. Slaughter MS. Will destination therapy be limited to large transplant centers? Tex
Heart Inst J. 2010.
129. Slaughter MS. Hematologic Effects of Continuous Flow Left Ventricular Assist
Mark S. Slaughter, M.D. November 15, 2016
45
Devices. J of Cardiovasc Trans Res. 2010 Dec.
130. Meyer AL, Malesha D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M.
Acquired von Willebrand Syndrome in Patients with an Axial Flow Left Ventricular
Assist Device. Circ Heart Fail. 2010 Nov 1.
131. Slaughter MS. The Ideal Conduit for Surgical Revascularization. The Quest for the
Holy Grail Continues. Circulation 2010Aug 31.
132. Slaughter MS. Introduction to LVAD Papers. J Card Surg 2010 Jul.
133. Slaughter MS, Myers TJ. Transcutaneous Energy Transmission for Mechanical
Circulatory Support Systems: History, Current Status, and Future Projects. J Card
Surg 2010 Jul.
134. Slaughter, MS. Long-Term Continuous Flow Left Ventricular Assist Device Support
and Eng-Organ Function: Prospects for Destination Therapy. J Card Surg 2010 Jul.
135. Bartoli CR, Giridharan GA, Litwak KN, Sobieski M, Prabhu SD, Slaughter MS,
Koenig SC. Hemodynamic Responses to Continuous versus Pulsatile Mechanical
Unloading of the Failing Left Ventricle. ASAIO J. 2010 Sep-Oct.
136. Bartoli CR, Wilson GC, Giridharan GA, Slaughter MS, Sherwood LC, Spence PA,
Prabhu SD, Koenig SC. A Novel Subcutaneous Counterpulsation Device: Acute
Hemodynamic Efficacy During Pharmacologically Induced Hypertension,
Hypotension, and Heart Failure. Artifical Organs. 2010 Jul.
137. Guan Y, Karkhanis T, Wang S, Rider A, Koenig SC, Slaughter MS, El Banayosy A,
Undar A. Physiologic benefits of pulsatile perfusion during mechanical circulatory
support for the treatment of acute and chronic heart failure in adults. Artif Organs.
2010 Jul.
138. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards
BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS; HeartMate II Investigators.
Continuous flow left ventricular assist device improves functional capacity and
quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010 April 27.
139. Slaughter MS, Naka Y, John R, Boyle A, Conte JV, Russell SD, Aaronson KD,
Sundareswaran KS, Farrar DJ, Pagani FD. Post-operative heparin may not be required
for transitioning patients with a HeartMatt II left ventricular assist system to long-
term warfarin therapy. J Heart Lung Transplant. 2010.
140. Maury, P, Delmas C, Trouillet C, Slaughter MS, Lairez O, Galinier M, Roncalli J,
Bertrand D, Mathevet L, Duparc A, Salvador M, Delay M, Dambrin C. First
experience of percutaneous radio-frequency ablation for atrial flutter and atrial
fibrillation in a patient with HeartMate II left ventricular assist device. J Interv Card
Mark S. Slaughter, M.D. November 15, 2016
46
Electrophysiol.
141. Slaughter MS, Ising MS, Tamez D, O’Driscoll G, Voskoboynikov N, Bartoli CR,
Koenig SC, Giridharan GA. Increase in circadian variation after continuous-flow
ventricular assist device implantation. J Heart Lung Transplant. 2010 Jun.
142. Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC,
Chen L, Boyle AJ, Chillcott S, Adamson RM, Blood MS, Camacho MT, Idrissi KA,
Petty M, Sobieski M, Wright S, Myers TJ, Farrar DJ; HeartMate II Clinical
Investigators. Clinical Management of continous-flow left ventricular assist devices
in advanced heart failure. J Heart Lung Transplant. 2010 Apr.
143. Coyle LA, Ising MS, Gallagher C, Bhat G, Kurien S, Sobieski MA, Slaughter MS.
Destination Therapy: One Year Outcomes in Patients with a Body Mass Index
Greater Than 30. Artif Organs. 2010 Feb.
144. Slaughter, MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al.
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist
Device. N Engl J Med 2009.
145. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG,
Miller LW, Deng M, Naka Y, Mancini, D. Impact of center volume on outcomes of
left ventricular assist device implantation as destination therapy: analysis of the
Thoratec HeartMate Registry, 1998 to 2005. Circ Heart Fail. 2009 Jan.
146. Boyle, AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, Frazier
OH, Heatley G, Farrar DJ, John R. Low thromboembolism and pump thrombosis with
the HeartMatt II left ventricular assist device: analysis of outpatient anti-coagulation.
J Heart Lung Transplant. 2009 Sep.
147. Slaughter MS, Sobieski MA, Tamez D, Horrell T, Graham J, Pappas PS,Tatooles
AJ, LaRose J. HeartWare miniature axial-flow ventricular assist device: design and
initial feasibility test Tex Heart Inst J. 2009.
148. Slaughter MS. Outcomes of Medicare Beneficiaries With Ventricular Assist
Devices. JAMA. 2009.
149. Slaughter MS, Bartoli CR, Sobieski MA, Pantalos GM, Giridharan GA, Dowling
RD, et al. Intraoperative evaluation of the HeartMate II flow estimator J Heart Lung
Transplant. 2009 Jan.
150. Koenig SC, Giridharan GA, Ewart DL, Schoeder MJ, Ionan C, Slaughter MS, et al
Human, bovine and porcine systematic vascular input impedances are not equivalent
Mark S. Slaughter, M.D. November 15, 2016
47
implications for device testing and xenotransplantation in heart failure. J Heart Lung
Transplant. 2008 Dec.
151. Koenig SC, Litwak KN, Giridharan GA, Pantalos GM, Dowling RD, Prabhu SD,
Slaughter MS, et al Acute hemodynamic efficacy of a 32-ml subcutaneous
counterpulsation device in a calf model of diminished cardiac function. ASAIO J.
2008 Nov-Dec.
152. Pisano C, Nutter A, Ziebarth C, Cooke G, Slaughter M, Silver MA. Can we detect
fatal heart failure? J Cardiac Failure 2008.
153. Lietz K, Long J, Kfour A, Slaughter M, Silver M, Milano C, et al. The Impact of
Center Volume on Outcomes of Left-Ventricular Assist Device Implantation as
Destination Therapy – Analysis of Thoratec Heartmate Registry 1998-2005
Circulation (2008).
154. Slaughter MS, Sobieski MA, Tatooles AJ, Pappas PS. Reducing Emboli in Cardiac
Surgery: Does it Make a Difference? Artif Organs. 2008 Nov.
155. Aggarwal S, Slaughter MS. Acute myocardial infarction complicated by cardiogenic
shock: role of mechanical circulatory support Expert Rev Cardiovasc Ther. 2008 Oct.
156. Slaughter MS, Sobieski MA, Gallagher C, Dia M, Silver MA Low incidence of
neurologic events during long-term support with the HeartMate XVE left ventricular
assist device Tex Heart Inst J 2008.
157. Slaughter MS, Sobieski MA II, Tamez D, Horrell T, Graham J, Pappas PS, Tatooles
AT, LaRose J Design Concepts and Initial Tests of a New Miniature Ventricular
Assist Device: The HeartWare MVAD™. Texas Heart Institute Journal September
2008.
158. Sobieski MA, Graham JD, Pappas PS, Tatooles AJ, Slaughter MS Reducing the
Effects of the Systemic Inflammatory Response to Cardiopulmonary Bypass: Can
Single Dose Steroids Blunt SIRS? ASAIO J. 2008 Mar-Apr.
159. Coye LA, Martin MM, Kurien S, Graham JD, Gallagher C, Silver MA, Slaughter
MS. Destination Therapy: Safety and Feasibility of National and International
Mark S. Slaughter, M.D. November 15, 2016
48
Travel. ASAIO J. 2008 Mar-Apr.
160. Slaughter MS, Sobieski MA, Gallagher C, Graham J, Brindise J, Stein R Fibrinolytic
Activation During Long-term Support With the HeartMate II Left Ventricular Assist
Device. ASAIO J. 2008 Jan-Feb.
161. Feldman CM, Khan SN, Slaughter MS, Sobieski M, Graham JD, Eaheart B, Silver
MA. Improvement in early oxygen uptake kinetics with left ventricular assist device
support. ASAIO J. 2008 Jul-Aug.
162. Koenig SC, Giridharan GA, Ionan C, Pantalos GM, Dowling RD, Prabhu S, Sobieski
MA, Slaughter MS. Systemic vascular input impedance in humans, calves and pigs:
Clinical implication with medical devices and xenotransplantation. J Heart and Lung
Transp 2007.
163. Slaughter MS, Jweied E. Managing mechanical valves with reduced anticoagulation.
Expert Rev Cardiovasc Ther. 2007 Nov.
164. Leitz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG,
Naka Y, Mancini D, Miller LW. Outcomes of Left Ventricular Assist Device
Implantation as Destination Therapy in the Post-REMATCH Era. Implications for
Patient Selection. Circulation. 2007 Jul 31.
165. Slaughter MS, Feldman CM, Sobieski MA, Silver MA, Martin MM, Kurien S,
Coyle LA, Pederson B. Utilization of acoustic signatures to identify HeartMate XVE
device end-of-life. J Heart Lung Transplant. 2007 Jun.
166. Slaughter MS, Tsui SS, El-Banayosy A, Sun BC, Kormos RL, Mueller DK, Massey
HT, Icenogle TB, Farrar DJ, Hill JD; IVAD Study Group. Results of a multicenter
clinical trial with the Thoratec Implantable Ventricular Assist Device. J Thorac
Cardiovasc Surg. 2007 Jun.
167. Slaughter MS, Sobieski MA, Martin M, Dia M, Silver MA. Home Discharge
Experience With the Thoratec TLC-II Portable Driver. ASAIO J. 2007 Mar-Apr.
168. Travis AR, Giridharan GA, Pantalos GM, Dowling RD, Prabhu SD, Slaughter MS,
Sobieski M, Undar A, Farrar DJ, Koenig SC. Vascular pulsatility in patients with a
pulsatile- or continuous-flow ventricular assist device. J Thorac Cardiovasc Surg.
2007 Feb.
169. Feldman CM, Silver MA, Sobieski MA, Slaughter MS. Management of Aortic
Insufficiency With Continuous Flow Left Ventricular Assist Devices: Bioprosthetic
Mark S. Slaughter, M.D. November 15, 2016
49
Valve Replacement. J Heart Lung Transplant. 2006 Dec.
170. Miller LW, Nelson KE, Bostic RR, Tong K, Slaughter MS, Long JW. Hospital costs
for left ventricular assist devices for destination therapy: lower costs for implantation
in the post-REMATCH era. J Heart Lung Transplant. 2006 Jul.
171. Slaughter MS, Sobieski MA, Koenig SC, Pappas PS, Tatooles AJ, Silver MA. Left
Ventricular Assist Device Weaning: Hemodynamic Response and Relationship to
Stroke Volume and Rate Reduction Protocols. ASAIO J. 2006 May-Jun.
172. McNicholas KW, Ivey TD, Metras J, Szentpetery S, Marra SW, Masters RG, Dilling
EW, Slaughter MS, Mack MJ. North American multicenter experience with the On-
X prosthetic heart valve. J Heart Valve Dis. 2006 Jan.
173. Sobieski MA 2nd, Pappas PS, Tatooles AJ, Slaughter MS. Embol-X intra-aortic
filtration system: capturing particulate emboli in the cardiac surgery patient. J Extra
Corpor Technol. 2005 Jun.
174. Slaughter MS. Destination therapy: the future is arriving. Congest Heart Fail. 2005
May-Jun.
175. Long JW, Kfoury AG, Slaughter MS, Silver M, Milano C, Rogers J, Delgado R,
Frazier OH. Long-Term, Destination Therapy With the HeartMate XVE Left
Ventricular Assist Device: Improved Outcomes Since the REMATCH Study. Congest
Heart Fail. 2005 May-Jun.
176. Sobieski MA 2nd, Slaughter MS, Hart DE, Pappas PS, Tatooles AJ. Prospective
study on cardiopulmonary bypass prime reduction and its effect on intraoperative
blood product and hemoconcentrator use. Perfusion. 2005 Jan.
177. Sobieski MA, George TA, Slaughter MS. The Thoratec Mobile Computer: Initial In-
Hospital and Outpatient Experience. ASAIO J. 2004 Jul-Aug.
178. Tatooles AJ, Pappas PS, Gordon PJ, Slaughter MS. Minimally invasive mitral valve
repair using the da Vinci robotic system. Ann Thorac Surg. 2004 Jun.
179. Slaughter M. Myocardial Recovery After Chronic Mechanical Assist Device
Support: Fact or Fiction? Congest Heart Fail. 2004 Mar-Apr.
180. Banbury MK, Kouchoukos NT, Allen KB, Slaughter MS, Berry G, Horvath KA. The
histologic characteristics of captured particulate emboli using the Embol-X intra-
aortic filter during cardiopulmonary bypass. Heart Surg Forum. 2003.
181. Sobieski MA 2nd, Slaughter MS, Hart DE, Pappas PS, Tatooles AJ. Peripheral
Cardiopulmonary Bypass With Modified Assisted Venous Drainage And
Transthoracic Aortic Crossclamp: Optimal Management For Robotic Mitral Valve
Mark S. Slaughter, M.D. November 15, 2016
50
Repair. Perfusion. 2003 Sep.
182. Slaughter MS, Pappas P, Tatooles A. Percutaneous Endoscopic Gastrostomy Tube in
a Patient with a Left Ventricular Assist Device. ASAIO J. 2003 Sep-Oct.
183. Banbury MK, Kouchoukos NT, Allen KB, Slaughter MS, Weissman NJ, Berry GJ,
Horvath KA; ICEM 2000 Investigators. Emboli capture using the Embol-X
intraaortic filter in cardiac surgery: a multicentered randomized trial of 1,289
patients.Ann Thorac Surg. 2003 Aug.
184. Mussivand T, Harasaki H, Litwak K, Slaughter MS, Gray LA Jr, Dowling TR,
Mueller R, Masters RG, Hendry PJ, Beck-Da-silva L, Davies R, Haddad H, Mesana
TG, Keon WJ. In vivo evaluation of the biocompatibility of the totally implantable
ventricular assist device (HeartSaver VAD). ASAIO J. 2003 Jul-Aug.
185. Cianci P, Lonergan-Thomas H, Slaughter M, Silver MA. Current and Potential
Applications of Left Ventricular Assist Devices. J Cardiovasc Nurs. 2003 Jan-Mar.
186. Slaughter MS, Silver MA, Farrar DJ, Tatooles AJ, Pappas PS. A New Method of
Monitoring Recovery and Weaning the Thoratec Left Ventricular Assist Device. Ann
Thorac Surg. 2001 Jan.
187. Slaughter MS, Pappas PS, Tatooles AJ. Modified implant technique for the
pneumatic HeartMate left ventricular assist system. J Congestive Heart Failure &
Circulatory Support 1999.
188. Zelinger A, Pappas P, Slaughter M, Tatooles A, Bhan A. Limitations of screening
transthoracic echocardiography in assessing intracardiac injury due to cardiothoracic
trauma: a role for intraoperative TEE during initial surgical repair. Video J
Echocardiography 1999.
189. Slaughter MS, Gordon PJ, Roberts JC, Pappas, PS. An unusual case of hypoxia from
benzocaine-induced methemoglobinemia. Ann Thorac Surg. 1999 Jun.
190. Baldwin DR, Slaughter MS, Park S, McFalls E, Ward HB. Coronary bypass grafting
for single vessel coronary artery disease: a 17-year review with short and long-term
follow-up. Chest. 1998 Mar.
191. Slaughter MS, Gerchar DC, Pappas PS. Modified minimally invasive technique for
greater saphenous vein harvesting. Ann Thorac Surg. 1998 Feb.
192. Smith PC, Slaughter MS, Petty MG, Shumway SJ, Kshettry VR, Bolman RM 3rd.
Abdominal complications after lung transplantation. J Heart Lung Transplant. 1995
Jan-Feb.
193. Slaughter MS, Braunlin E, Bolman RM 3rd, Molina JE, Shumway SJ. Pediatric heart
transplantation: results of 2- and 5-year follow-up. J Heart Lung Transplant. 1994 Jul-
Aug.
Mark S. Slaughter, M.D. November 15, 2016
51
194. Slaughter MS, Kshettry VR, Smith PC, Foker JE. Internal mammary artery for
arterial pressure monitoring after pediatric cardiac operations. Ann Thorac Surg. 1993
Dec.
195. Slaughter MS, Olson MM, Lee JT Jr, Ward HB. A fifteen-year wound surveillance
study after coronary artery bypass. Ann Thorac Surg. 1993 Nov.
196. Pearce WH, Slaughter MS, LeMaire S, Salyapongse AN, Feinglass J, McCarthy WJ,
Yao JS. Aortic diameter as a function of age, gender, and body surface area. Surgery.
1993 Oct..
197. Slaughter MS, Nielsen K, Bolman RM 3rd. Extracorporeal membrane oxygenation
after lung or heart-lung transplantation. ASAIO J. 1993 Jul-Sep.
198. Slaughter MS, Pomerantz RA, Murad T, Hines JR. Infiltrating syringomatous
adenoma of the nipple. Surgery. 1992 Jun;111(6):711-3.
199. Brown PS Jr, Nath R, Votapka T, Slaughter M, Meyers SN, Talano JV, Joob A.
Traumatic ventricular septal defect and disruption of the descending thoracic aorta.
Ann Thorac Surg.1991 Jul;52(1): 143-4. No abstract available.
200. Sawchuck A, Canal D, Grosfeld JL, Slaughter M, Gardner G, O’Connor T, Behrman
D. Electrical pacing of the Roux limb resolves delayed gastric emptying. J Surg Res.
1987 Jun.
201. Sawchuk A, Canal D, Slaughter M, Bearman D, O’Connor T, Grosfeld JL. A
comparison between fructose 1, 6-diphosphate, glucose, or normal saline infusions
and species-specific blood exchange transfusions in the treatment of bowel ischemia.
Surgery. 1986 Oct.
Clinical Trials:
1. HeartWare 004A
A Prospective, Randomized, Controlled, Unblinded, 2014-Ongoing
Multi-Center Clinical Trial to Evaluate the HeartWare
Ventricular Assist Device System for Destination Therapy of Advanced Heart Failure
IRB#13.0593
2. PREVENT 2015-2016
Prevention of HeartMate II Pump Thrombosis through Clinical Management
(PREVENT)
IRB#14.1161
Mark S. Slaughter, M.D. November 15, 2016
52
3. LEVO-CTS 2015-Ongoing
A Double-Blind, Randomized, Placebo-controlled Study of Levosimendan in
Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery
Requiring Pulmonary By-pass;LEVO-CTS
IRB#15.0403
4. Momentum 3 2014-Ongoing
Multi-Center Study of MagLev Technology in Patients Undergoing MCS
Therapy with HeartMate 3
IRB#15.0347
5. LAAOS III 2015-Ongoing
Left Atrial Appendage Occlusion Study III
IRB#14.0085
6. HW-PAS-03 2014-2015
A Multi Center, Post Approval Study Providing Continued Evaluation and
Follow-up on Patients Who Received a HeartWare Ventricular Assist System
During IDE Trials for the Treatment of Advanced Heart Failure
IRB#13.0069
7. ROADMAP 2011- 2013
Risk Assessment and Comparative Effectiveness Of Left Ventricular Assist
Device and Medical Management in Ambulatory Heart Failure Patients
IRB#11.0529
8. CTSN
Evaluation of Outcomes Following Mitral Valve Repair/Replacement in 2010-2011
Severe Chronic Ischemic Mitral Regurgitation
NHLBI, NINDS & CIHR
IRB #10.0399
9. CTSN 2010-2011
Surgical Interventions for Moderate Ischemic Mitral Regurgitation
NHLBI, NINDS & CIHR
IRB #10.0398
10. LAAx, Inc. 2009-2011
Exclusion of the Left Atrial Appendange (LAA) with the LAAx, Inc.
TigerPaw System
University of Louisville
NCT00962702
11. Evaluation of the Levacor Ventricular Assist Device as a Bridge to Cardiac 2010 – 2011
Transplantation Clinical Trial
Mark S. Slaughter, M.D. November 15, 2016
53
University of Louisville
IRB#09.0494
12. Procedures and Outcomes in Heart Transplantation: 25 Years 2009 – 2010
Experience at Jewish Hospital
IRB #09.0362
13. Levitroni 2009-2010
CentriMag VAS: Failure-to-Wean from Cardiopulmonary Bypass Trial
IRB #09.0159
14. Retrospective review of patients with surgical treatment 2008-2011
of advanced heart failure
Principle Investigator
15. SUNSHINE HEART, Incorporated 2008-Present
C-Pulse™ Implantable Counterpulsation Pump (ICP)
U.S. Feasibility Study
IRB #08.0487
16. HeartWare, Inc. 2008-2009
Evaluation of the HearWare Left Ventricular Assist Device (LVAD) System for the
Treatment of Advanced Heart Failure (Protocol Number HW003, Revision 4.0)
IRB #08.0453/IDE #G070199
17. Myocardial Regeneration Using Cardiac Stem Cells Harvested 2008 – Present
From Right Atrial Appendages in Patients with Ischemic Cardiomyopathy
IRB #062.067
18. Merck A Randomized, Multicenter, Double-Blind, Group-Sequential 2008-Present
Study to Evaluate the Efficacy, Immunogenicity, and Safety of a Single Dose
of Merck 0657nl Staphylococcusaureus Vaccine (V710) in Adult Patients
Scheduled for Cardiothoracic Surgery.IRB #
19. NovoNordisk 2008-Present
A Prospective, randomized, double-blind, placebo controlled, parallel group, multi-
center Study to evaluate the efficacy of activated recombinant Factor VII for early control of
hemorrhage in high-risk cardiac surgery. IRB #
20. CVRX: Rheos Baroreflex Hypertension Therapy System Pivotal Trial. 2007–Present
IRB # 4325
21. CVRX: Rheos Baroreflex Hypertension Therapy System Feasibility Trial. 2006-2007
IRB # 4232
Mark S. Slaughter, M.D. November 15, 2016
54
22. SCCOR: The Epidemiology of Bleeding and Clotting in Patients 2006-Present
Undergoing Heart Transplantation of Left Ventricular Assist Devices.
IRB # 4108
23. SCCOR: The Epidemiology of Ventricular Assist Devices – Related 2006-Present
Infections.
IRB # 4107
24. Momentum Trial: Multicenter Trial of the Orqis CRS for the Enhanced 2006-Present
Treatment of CHF Unresponsive to Medical Therapy.
IRB # 4014
25. A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study 2005-Present
of the Safety and Efficacy of Human Recombinant Soluable Complement
Receptor Type 1 (TP10) in Adult Women Undergoing Cardiopulmonary Bypass Surgery.
IRB # 3907
26. HeartMate II LVAS Pivotal Study. 2005-Present
IRB # 3879
27. Pathophysiologic Benefits of Continuous and Pulsatile Ventricular 2004-Present
Assist Trial.
IRB # 3805
28. ZymoGenetics
2003
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Factor XIII-
Administration in Patients Undergoing First-time Cardiopulmonary Bypass for Myocardial
Revascularization.
29. Mitral Valve Replacement using the daVinci Surgical System. 2003-Present
IRB # 3524
30. HeartMate LVAS Cardiogenic Shock Complicating An 2003-Present
Acute Myocardial Infarction IRB # 3523
31. A Study to Evaluate Safety and Performance of the Sutureless 2003-2004
Anastomotic System (SAS) for Creating Anastomosis.
IRB # 3522
32. Thoratec Destination Therapy Registry. 2003-Present
IRB # 3519
33. Coverge – Study to Evaluate Safety and Performance of the 2003-2005
Sutureless Anastomotic System (SAS) for Creating Anastomosis
Principal Investigator
34. Prospective, Non-randomized, Non-blinded, Multi-Center, Clinical 2002-2003
Mark S. Slaughter, M.D. November 15, 2016
55
Evaluation of the Syncrus Internal Cardioversion System in the Treatment of Patients
who develop Post-Operative Atrial Fibrillation. IRB # 3409
35. Prevent IV: A Phase III, Multi-Center Randomized, Double Blind, 2002-2004
Placebo-Controlled Trial of the Ex Vivo treatment with CGT003 of Coronary Artery Vein
grafts in Patients Undergoing Coronary Artery Bypass Graft Procedures.
IRB # 3404
36. Atrial Septal Defect Repair using the daVinciSurgical System.
2002
IRB # 0070
37. Clinical Evaluation of the Thoratec Implantable Ventricular Assist 2002-2004
Device (IVAD). Principal Investigator.
IRB # 3307
38. ISHLT Mechanical Circulatory Support Device Database. 2002-Present
Principal Investigator.
IRB # 3300
39. Clinical Evaluation of Acorn Cardiac Support Device Therapy in Patients 2001-2004
with Dilated Cardiomyopathy - U.S. Randomized trial Principal Investigator.
IRB # 3211
40. Mitral Valve Repair Using the daVinci Surgical System. 2001-2003
Multi-Center Clinical Trial. Principal Investigator.
IRB # 3200
41. Pre-Clinical Animal Testing of HeartSaver LVAD. Chronic In-vivo and 2001-2002
Acute Performance Testing. Principal Investigator.
ACC # 01-079
42. Comparison of LVAD Weaning Methods and its Effect on Left Ventricular 2001
Wall Stress. Principal Investigator.ACC # 01-049
43. Effects of Chronic Mechanical Unloading by a Left Ventricular Assist 2001-2003
Device on Myofilament Activation in Heart Failure. Principal Investigator.
IRB # 3184
44. Home Discharge Clinical Evaluation of the Thoratec TLC-II Driver in the 2001-2004
VAD System. Principal Investigator.
IRB# 0047
45. EMBOL-X Inter-aortic Filtration System. Principal Investigator. 2000-Oct 2002
MIC Project # 912
46. Aria Coronary Artery Bypass Graft U.S. Phase I Trial. AEGIS/U.S. 1999-July 2000
Mark S. Slaughter, M.D. November 15, 2016
56
Clinical Trial. Principal Investigator.
MIC Project # 893
47. On-X Prosthetic Heart Valve Aortic and Mitral Models. Phase 1999-Present
III trial. Principal Investigator.
MIC Project # 864
48. Thoratec TLC-II Portable Driver System. Principal Investigator. 1999-2000
MIC Project # 849
49. Pumpless ECMO for ARDS. Principal Investigator. 1999-2000
Medtronic equipment grant support $3000
50. Suppression of the Systemic Inflammatory Response of Cardiopulmonary 1999-2000
Bypass and its Effect on Clinical Outcomes in Patients Undergoing Coronary Artery
bypass Grafting. Principal Investigator. Med Fund Grant Support $30,000.
MIC Project # 835
51. C-SMART (Cardiomyoplasty - Skeletal Muscle Assist Randomized Trial). 1998
Phase III trial of Dynamic Myoplasty for Congestive Heart Failure. Principal Investigator.
MIC Project # 814
52. The Use of Leukine to Stimulate Healing of Leg wounds After Coronary 1998-1999
Artery Bypass Graft Surgery. Investigator. Immunex Grant Support $20,000.
MIC Project # 802
53. A study of the Conversion Efficacy and Safety of Repeated Intravenous 1996-1997
Doses of Ibutilide in Patients with Atrial Flutter or Atrial Fibrillation Following Coronary
Artery Bypass Surgery. Investigator.
Abstracts: 1. “Cardiac Gene Expression Profile Distinguishes African-American and European-American Heart
Failure Patients” Halder I, Causer V, McTiernan C, Lemster B, Ramani R, Prabhu S, Slaughter M, Dries D, Tseng G, McNamara D, ACC Conference, Chicago. April 2016
2. “Long-term Follow up of the Impact of Cardiac Resynchronization Therapy on Clinical and
Arrhythmic Outcomes in Continuous Flow Left Ventricular Assist Device Recipients” Familtsev D, Hottigoudar R, Ghotra A, Slaughter M, Trivedi J, Sutton B, Deam G, McCants K, Lenneman A, Birks E, Gopinathannair R. 2015 May, Heart Rhythm Society. (Oral)
3. “Correlating Modified Surgical MAZE lesions in the Left Atrium with Propensity of Atrial Tachycardia
Development During Follow-up” Mar P, Lakkireddy D, Tu Y, Gunda S, Lenneman C, Slaughter M, Trivedi J, Biase L, Natale A, Gopinathannair R. 2015 May, Heart Rhythm Society. (Oral)
Mark S. Slaughter, M.D. November 15, 2016
57
4. “Heart Transplant Survival Based on Recipient and Donor Risk Scoring: A UNOS Database Analysis” Trivedi J, Ising M, Cheng A, Lenneman A, Birks E, Slaughter MS 2015 April, International Society for Heart and Lung Transplantation Annual Meeting. (Oral)
5. “Impact of Cardiac Resynchronization Therapy on Clinical Outcomes in Patients with Continuous-
Flow Left Ventricular Assist Devices” R. Gopinathannair, E. Birks, J. Trivedi, K. McCants, B. Sutton, A. Deam, M. Slaughter, R. Hottigoudar 2015 March, Journal of Cardiac Failure.
6. “Demonstration of Low Frequency Speed Modulation of Miniature Rotary Blood Pumps in a Large
Animal Model” K. Soucy, G. Guruprasad, M. Sobieski, Slaughter MS, Koenig S. 2014 October, Biomedical Engineering Society Annual Meeting. (Oral)
7. “Preoperative Aspirin Use and its Effect on Adverse Events in Patients Undergoing Cardiac Surgery”
Huang J, Donneyong M, Trivedi J, Slaughter MS. 2014 April, Society of Cardiovascular Anesthesiologists Annual Meeting, New Orleans, LA. (ePoster presentation)
8. “Myocardial Regeneration and Recovery with Extracellular Matrix and LVAD Support”. 34th Annual
ISHLT Meeting. April 13, 2014. (Oral)
9. “Comparison of Total Artificial Heart and Biventricular Assist Device Support as Bridge-to-Transplantation” 34th Annual ISHLT Meeting. April 11, 2014 (Oral-Allen Cheng)
10. “Early Post-op anticoagulations: Is It Needed and What to Use?” 34th Annual ISHLT meeting. April 10,
2014, San Diego, CA. (Oral)
11. HeartWare” Small group Session ISHLT Academy MCS Meeting pre 34th Annual ISHLT Meeting. April 8th, 2014. San Diego CA (oral)
12. “Tailoring Pumps to Patients” Surgical Considerations- ISHLT Academy MCS Meeting- 34th Annual
ISHLT Meeting. April 7th, 2014. San Diego CA (oral)
13. “Extended Extra-aortic Counterpulsation Support with C-Pulse Device Does Not Alter Aortic Wall Structure” 34th Annual ISHLT Meeting. April 11, 2014. (Poster)
14. “Impact of Device Design and Patient Management on the Incidence of Neurologic Events after
HVAD Left Ventricular Assist Device”. 34th Annual ISHLT Meeting. April 11, 2014. (Oral) 15. Slaughter MS, Cheng A. Left Ventricular and Vascular Biomechanics in Advanced Heart Failure
Patients Supported by Continuous and Pulsatile Left Ventricular Assist Devices. 9th Annual Academic Surgical Congress. February 4-6, 2014. (Poster)
16. Goldstein DJ, Aaronson KD, Tatooles A, Silvestry SC, Jeevanandam V, Gordon RA, Hathaway DR,
Najarian KB, Slaughter MS. “Gastrointestinal Bleeding in Recipients of the HeartWare Ventricular Assist System”. AHA Scientific Sessions 2013 Annual Meeting. November 19, 2013. (Oral Session)
17. Milano CA, Pagani FD, Slaughter MS, Pham,DT, Hathaway DR, Najarian KB, Aaronson KD. “Clinical
Outcomes Following Implantation of a Centrifugal Flow Left-Ventricular Assist Device and
Mark S. Slaughter, M.D. November 15, 2016
58
Concomitant Cardiac Valve Procedures”. AHA Scientific Session 2013 Annual Meeting. November 19, 2013. (Oral Session)
18. Slaughter MS. “Universal Apical Access System for Left Ventricular Assist Implantation: A
Preliminary Feasibility Study”. ISRBP 2013 Annual Meeting. September 27, 2013. (Abstract accepted July for Oral Presentation)
19. Hottigoudar R, Slaughter MS, Birks EJ. “Cardiac Resynchronization Therapy does not Offer Additive
Benefit over ICD in Patients with Continuous Flow LVAD.” 34th Annual Heart Rhythm 2013, Denver, CO. (Abstract accepted February 2013)(Poster)
20. Lenneman AJ, Combs P, Rhode S, Vessels K, McCants K, Singh R, Birks E, Slaughter MS.
“Management and Outcomes of Ventricular Assist Device Patients with Suspected Pump Thrombosis. 33rd ISHLT Annual Meeting. Montreal, CAN. (Poster)
21. Jorde UP, Khushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof D, Kormos RL,
Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park, SJ. “Two-Year Outcomes in the Destination Therapy Post-FDA-Approval Study with a Continuous Flow LVAD: Prospective Study Using the INTERMACS Registry.” 33rd International Society of Heart & Lung Transplantation Annual Meeting, Montral CAN. (Abstract accepted January 2013) (Oral)
22. Combs PS, Raheia P, Slaughter MS, Birks EJ, “Predisposition to Infection and Bleeding in Mechanical
assist Devices (LVADs) Recipients after Dental procedures: A single Center Experience” 33rd International Society of Heart & Lung Transplantation Annual Meeting, Montral CAN. (Abstract accepted January 2013) (Oral)
23. Ranjit J, Aaronson K, Pae W, Acker M, Hathaway D, Najarian K, Slaughter MS. “Driveline Infections
and Sepsis in Patients Receiving the HVAD System as a Left-Ventricular Assist Device” 33rd International Society of Heart and Lung Transplantation Annual Meeting, Montreal CAN . (Abstract accepted January, 2013) (Oral)
24. Ranjit J, Aaronson K, Pagani F, Hathaway D, Swartz M, Najarian K, Slaughter MS. “Impact of
Demographic and On-Pump Factors on Post-Transplant Survival Following Support with the HVAS System” 33rd International Society of Heart and Lung Transplantation Annual Meeting, Montreal CAN . (Abstract accepted January, 2013) (Oral)
25. Combs PS, Sobieski ME, Trivedi JR, Creamer EF, McCants KC, Birks EJ, Singh R, Slaughter MS.
“Education level and insurance do not impact mid-term survival after left ventricular assist device implantation” 33rd International Society of Heart and Lung Transplantation Annual Meeting, Montreal CAN . (Abstract accepted January, 2013) (Oral)
26. Aggarwal A, Bhat G, Tatooles G, Slaughter MS, Jorde U, Brewer R, Chen L, Farrar D, Sundareswaran
K. “Racial Differences in over 1000 Patients with Continuous Flow Left Ventricular Assist Devices” 33rd International Society of Heart and Lung Transplantation Annual Meeting, Montreal CAN . (Abstract accepted January, 2013) (Poster)
Mark S. Slaughter, M.D. November 15, 2016
59
27. Donneyoung, M, Trivedi JR, Williams ML, Slaughter MS. “Association of Prior Implantation of Heartmate II Left Ventricular Assistive Device With Post-Heart Transplant Mortality” 33rd International Society of Heart and Lung Transplantation Annual Meeting, Montreal CAN.. (Abstract accepted January, 2013) (Oral)
28. McGee Jr EC, Aaronson K, Birks EJ, Boyce SW, Cotts WG, Najjar SS, Pagani FD, Hathaway D, Jacoski
MV, Najarian KB, Slaughter MS. “An Examination of Survival by Sex in the HVAD BTT and CAP Trials.” Accepted for American Heart Association 2012 Scientific Trials, Los Angeles CA, November 04, 2012 (Poster)
29. Cohn W, Slaughter MS, Parkin R, LaFontaine D, Peters W, “Transcutaneous-Powered
Electrohydraulic Counterpulsation System For Ambulatory Non-Obligatory Chronic Heart Failure Treatment” TCT 2012 Conference, Miami Beach, FL, October 23, 2012 (Poster).
30. Keeling WB, Williams ML, Slaughter MS, Zhao S, Puskas JD. Off-Pump and On-Pump Coronary
Revascularization in Patients with Low Ejection Fraction: A Report from the STS National Database. STS Annual Meeting, January 2013. (Abstract accepted August 2012).
31. Birks EJ, Slaughter MS, Boyce S, McGee E, Cotts WG, Najjar SS, Pagani FD, Hathaway D, Jacoski MJ,
Najarian K, Aaronson KD. “Improved Quality of Life and Functional Capacity for Patients receiving the HVAD® Pump” Heartware QOL abstract (accepted as an oral presentation at the AHA, August 2012)
32. Bourque K, Cotter C, Dague C, Sobieski M, Koenig S, Slaughter MS. “In Vivo Evaluation of LVAD
Artificial Pulse Parameters and Synchrony with the Native Heart.” 20th Congress of the International Society for Rotary Blood Pumps Meeting, Istanbul, Turkey, September 20-22, 2012. (Abstract submitted August 2012)
33. Keeling WB, Trivedi J, Williamitis C, Singh R, Slaughter MS, Williams ML. “Preoperative Anemia and
Low Body Mass Index but Not Female Gender as Risk Factors for Increased Transfusion Following Isolated Coronary Artery Bypass Grafting.” American Heart Association Scientific Sessions, Los Angeles, CA, November 2012 (Abstract submitted June 2012)
34. Soucy KG, CJ Benzinger, AC Ansert, KP Holley, TC Spalding, GA Giridharan, MA Sobieski, MS
Slaughter, and SC Koenig. Development of an Apical Left Ventricular (ALV) cannula system for aortic valve bypass. Submitted to Biomedical Engineering Society (BMES) annual conference, October 24-27, 2012, Atlanta, GA.
35. Soucy KG, JD Graham, CJ Benzinger, GA Giridharan, MA Sobieski, SC Koenig, and MS Slaughter. Flow
dynamics and hemocompatibility of an apical left ventricular cannula. 58th ASAIO Conference, June 14-17, 2012, San Francisco, CA.
36. Buller M, Sobieski M, Soucy K, Giridharan G, Slaughter MS, Investigation of Myocardial Recovery in a
Chronic Ischemic Heart Failure Bovine Model. European Society of Artificial Organs (submitted April 2012)
37. Hottigoudar RU, Deam AG, Birks E, McCants K, Slaughter MS, Gopinathannair R. Catheter Ablation
of Atrial Flutter in Patients with HeartMateII Left Ventricular Assist Device Improves Symptoms of
Mark S. Slaughter, M.D. November 15, 2016
60
Right Ventricular Dysfunction. International Society of Heart and Lung Transplantation Annual Meeting, Prague, Czech Republic April, 2012. (poster)
38. Sobieski M, Schwartz S, Trivedi J, Williams ML, Slaughter MS, Use of Novel Thrombosis Index of Risk
(TIR) as Indicator for Left Ventricular Assist Device (LVAD) Thrombosis. International Society of Heart and Lung Transplantation Annual Meeting, Prague, Czech Republic April, 2012. (poster)
39. Trivedi JR, Slaughter MS, McCants KC, Birks EJ, Meyer A, Williams ML. Panel Reactive Antibody in
Bridge to Transplant Left Ventricular Assist Device Patients: Impact on Patient Survival after Cardiac Transplant. International Society of Heart and Lung Transplantation Annual Meeting, Prague, Czech Republic April, 2012. (oral)
40. Adamson RM, John R, Goldstein D, Park SJ, Milano CA, Tatooles AJ, Sundareswaran KS, Farrar DJ,
Slaughter MS. Heparin May not be needed as a Transition to long term Warfarin Therapy in LVAD Destination Therapy Patients. International Society of Heart and Lung Transplantation Annual Meeting (Abstract Submitted November 2011).
41. Beache GM, El-Baz AS, Chug AR, Loughran J, Elmore JB, Bolli R, Leri A, Kajstura J, Anversa P,
Slaughter MS. Visualization of Autologous Adult Cardiac Stem Cell Effect in Humans using Multi-modal MRI Characterization. Accepted for Annual Meeting of the Society of Cardiovascular Medical Research, February 2012. (Abstract submitted October 2011)
42. Dowling RD, Spence Pa, Warren S, Tompkins L, Sandova M, Giridharan GA, Sherwood, Gratz E,
Spanier G, Lederer L, Bruck S, Slaughter M, Koenig SC. Development of a Long-Term Superficial Device for Partial Circulatory Support. Accepted for HFSA Meeting, Boston, MA, September 2011.
43. Issing M, Sobieski MA, Slaughter MS, Koenig SC, Guruprasad GA. Hemodynamic Responses to
Continous Flow LVAD Speed Modulation in Computer Simulation and in-vitro Mock Loop Studies. Accepted for Annual Meeting of The International Society for Rotary Blood Pumps, Louisville, KY, September, 2011 (Poster)
44. Soucy K, Koenig S, Sobieski M, Slaughter M, Giridharan G. “Fault Detection Algorithm for Rotary
Ventricular Assist Devices.” 2011 Biomedical Engineering Society Annual Meeting, Hartford, CT, October 12 – 15, 2011 (abstract accepted June 2011)
45. Bartoli C, Brittain K, Sobieski M, Giridharan G, Wead W, Dowling R, Slaughter M, Prabhu S, Koenig S.
“Acute Hemodynamic Responses to Partial vs. Full Unloading of the Heart with a Continuous-Flow LVAD.” 2011 Biomedical Engineering Society Annual Meeting, Hartford, CT, October 12 – 15, 2011 (abstract accepted June 2011)
46. Ising M, Koenig S, Sobieski M, Slaughter M, Giridharan G. “Flow Modulation Algorithms for Intra-
Aortic Rotary Blood Pumps to Reduce Coronary Steal.” 2011 Biomedical Engineering Society Annual Meeting, Hartford, CT, October 12 – 15, 2011 (abstract accepted June 2011) PMID:23644613
47. Brisco MA, Sundareswaran KS, Milano CA, Feldman D, Ewald G, Slaughter M, Farrar D, Goldberg LG.
“Atrial Arrhythmias in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs): The
Mark S. Slaughter, M.D. November 15, 2016
61
Incidence, the Risk, the Consequences.” American Heart Association (AHA) Scientific Sessions, Orlando, FL, November 12 – 16, 2011
48. Brisco MA, Sundareswaran KS, Milano CA, Feldman D, Eewald G, Slaughter M, Farrar D, Goldberg LR. “Risk and Impact of Early and Late Ventricular Arrhythmias in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs). American Heart Association (AHA) Scientific Sessions, Orlando, FL, November 12 – 16, 2011 (Abstract Submitted June 2011)
49. Williams ML, Trivedi JR, He X, Slaughter MS. “STS Database Report: Lower Pre-operative
Hematocrit Predicts Adverse Outcomes After Coronary Artery Bypass Graft Surgery and Helps Explain Gender Differences.” Southern Thoracic Surgical Association Annual Meeting, San Antonio, TX, November, 2011. (Abstract Submitted April 2011)
50. Williams ML, Trivedi JR, Meyer AL, Davis J, Slaughter MS. “Driveline Infection in Bridge to Transplant Patients: Should Transplant Status be Upgraded?” Southern Thoracic Surgical Association Annual Meeting, San Antonio, TX, November, 2011. (Abstract Submitted April 2011)
51. Slater AD, Coffee A, Pappas P, Bresticker M, Pagni S, Beckman D, Wozniak T, Greason K, Ganzel BL, Rousou A, Austgen C, Stoddard M, Slaughter MS. “Prospective, Multicenter, Single Arm Investigation of a Novel Externally Applied Left Atrial Appendage (LAA) Occlusion Device.” Southern Thoracic Surgical Association Annual Meeting, San Antonio, TX, November 11, 2011. (Abstract Accepted May 2011)
52. Williams ML, Trivedi JR, Birks EJ, McCants KC, Sobieski MA, Slaughter MS. “Patient Outcomes after
Pump Stoppage in Continuous Flow Left Ventricular Assist Devices.” Southern Thoracic Surgical Association Annual Meeting, San Antonio, TX, November, 2011. (Abstract Submitted April 2011)
53. Williams ML, Trivedi JR, Slater AD, Pagni S, Ganzel BL, Slaughter MS. “Poor Mid-term Outcomes for
Surgery for Active Infective Endocarditis in Chronic Renal Failure Patients.” Southern Thoracic Surgical Association Annual Meeting, San Antonio, TX, November, 2011. (Abstract Submitted April 2011)
54. Cannon RM, Trivedi JR, Bland JN, Dwivedi A, Ross CB, Slaughter MS, Richardson JD, Williams ML.
“Traditional Open Repair of Traumatic Thoracic Aortic Injury Remains Relevant in the Endovascular Era.” Abstract Accepted to American College of Surgeons Annual Meeting, October 2011.
55. Slaughter MS, Birks E, Sobieski M, Ising m, Sherwood L, Hawes M, et al. “Pre-clinical GLP study of Impella 2.5 (Abiomed, Danvers, MA) for 5-day left ventricular (LV) support.” Abstract Accepted for ASAIO Annual Meeting, Washington, D.C., June, 2011.
56. Giridharan GA, Bartoli C, Soucy K, Sobieski MA, Koenig SC, Slaughter MS. Effects of Pulsatile Flow
and Continuous Flow Ventricular Assist Device Failure on Hemodynamics and End-Organ Blood Flow. Abstract Accepted for ASAIO 2011, Washington, D.C., June 2011.
57. Graham JD, Sharp MK, Koeniq SC, Giridharan G, Sobieski MA, Slaughter MS. Treatment of Severe
Aortic Stenosis: Development and Feasibility Testing of an Aortic Valve Bypass Apical Cannula. Proceedings of the ASME 2011 Summer Bioengineering Conference, Farmington, PA, June 22-25, 2011.
Mark S. Slaughter, M.D. November 15, 2016
62
58. Cowger J, Sundareswaran K, Rogers JG, Park SJ, Pagani FD, Bhat G, Jaski B, Farrar DJ, Slaughter MS.
The HeartMate II Risk Score: Predicting Survival in Candidates for Left Ventricular assist Device Support. Abstract Accepted for ISHLT, San Diego, CA, April 2011.
59. Sai-Sudhakar CB, Brewer RJ, Emani S, Slaughter MS, ravi Y, Sunderswaran, Farrar DJ, John R. Patients with Low Compared to High Body Mass Index Gain More Weight After Continuous Flow LVAD Implant. Abstract Accepted for ISHLT, San Diego, CA, April 2011.
60. Slaughter MS, Aaronson KD, Boyce S, Miller LW, McGee EC, Cotts WG, Acker MA, Jessup ML, Gregoric ID, Loalka P, Frazier OH, Jeevandandam V, Anderson AS, Kormos RL, Teuteberg JJ, Pagani FD, Bittman RM, Hathaway DR. HVAD BTT Pivotal Trial and Continued Access Program (ADVANCE): Interim Report of the Expanded Study. Abstract Accepted for ISHLT Meeting, San Diego, CA, April 15, 2011.
61. “Continuous Flow Ventricular Assist Devices Are Associated With Increased Gastrontestinal
Hemorrhage.” Cannon RM, Trivedi JR, Davis EG, McMasters KM, Slaughter MS. Quick Shot Presentation at Southwestern Surgical Congress, Honolulu, HI, April 2011.
62. Pierson RN, Slaughter MS. HVAD BTT Pivotal Trial and Continued Access Program (ADVANCE):
Interim Report of the Expanded Study. Abstract accepted for ISHLT Meeting, San Diego, CA, April 15, 2011.
63. Birks EJ, Combs P, Vessels K, Rhode S, Prabhu S, Williams M, McCants K, Slaughter M. An Analysis of the Capacity Required and Typical Clinical Problems Encountered With An Expanding BTT and DT VAD Program. Abstract Accepted for ISHLT Meeting, April 2011, San Diego, CA.
64. Starling R, Meyer DM, Martin T, Slaughter MS, Bonde P. National Trends in Readmission (REA) Rates Following Left Ventricular Assist Device (LVAD) Therapy. Abstract Accepted for ISHLT Meeting, San Diego, CA, April 14, 2011.
65. Levy W, Hathaway D, Miller L, Boyce S, Cotts W, McGee E, Jessup M, Acker M, Slaughter MS, Aaronson K. Application of the Seattle Heart Failure Model to the HeartWare Bridge to Transplant US Trial. ACC 2011 Scientific Session. April 2-5, 2011. New Orleans, LA.
66. Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steldley DE, Ewald GA, Farrar DJ, Slaughter
MS. Outcomes in Advanced Heart Failure with Left Ventricular Assist Devices for Destination Therapy. AHA Scientific Session 2010, November 16, 2010, Chicago, IL.
67. Rogers J, Tatooles A, Park SJ, Steidley E, Horstmanshof D, Pae W, Starling R, Farrar D, Slaughter, MS.
Outcomes of Mechnical Circulatory Support for Destination Therapy in NYHA Class IIIB Patients. AHA 2010 Scientific Sessions. Nov. 13-17. Chicago, IL
68. Slaughter MS. Heart Transplant Vs. Left Ventricular Assist Device (LVAD) in Heart Transplant Eligible Patients. STSA 57th Annual Meeting. Nov. 3-6, 2010. Orlando, FL.
Mark S. Slaughter, M.D. November 15, 2016
63
69. Pagni, S, Dwivedi AJ, Ganzel BJ, Williams, ML, Trivedi, JR, Mascio CE, Ross C, Slaughter, MS. Thoracic Aortic Mobile Thrombus (TAMT): Is There a Role for Early Surgical Intervention? AATS Aortic Symposium. April 29-30, 2010. New York, NY
70. Williams ML, Ganzel B, Slater D, Slaughter M, Edmonds H, Pagni S. Antegrade versus Retrograde Cerebral Perfusion in Ascending Aortic Dissection. AATS Aortic Syposium. April 29-30, 2010. New York, NY.
71. Slaughter MS, Giridharan GA, Aggarwal S, Sobieski M, Tamez D, LaRose J, Sherwood L, Koenig SC.
Design and Feasibility Testing of a Miniaturized Transapical Mechanical Circulatory Support Device: MVAD. International Society for Heart and Lung Transplantation. April 21-24, 2010; Chicago, IL.
72. Slaughter MS, Rogers JG, Blue L, Lodge AJ, Tatooles AJ, Bhat G, Sobieski M, Milano CA. Destination
Therapy: Improving Outcomes with Continuous Flow LVADs. International Society for Heart and Lung Transplantation. April 21-24, 2010; Chicago, IL.
73. Moazami N, Sun B, Milano C, John R, Conte J, Adamson R, Pagani F, Frazier OH, Farrar D, Slaughter
MS. Pump Replacement for LVAD Failure Can Be Done Safely and Is Associated with Low Mortality. International Society for Heart and Lung Transplantation. April 21-24, 2010; Chicago, IL.
74. Slaughter MS, Bostic R, Rogers JG, Russo MJ, Miller LW. Changing Costs of Mechanical Circulatory
Support: Impact of Era and Device. International Society for Heart and Lung Transplantation. April 21-24, 2010; Chicago, IL.
75. Coyle LA, Gallagher CT, Bhat G, Pappas PS, Slaughter MS, Tattoles AJ. Quality of Life in Patients
Supported Two Years with a Continuous Flow Left Ventricular Assist Device as Destination Therapy. International Society for Heart and Lung Transplantation. April 21-24, 2010; Chicago, IL.
76. Aggarwal S, Luftman K, Bowles R, McCants K, Prabhu S, Dowling RD, Slaughter MS. Mid-Term
Results of Campath Induction and Steroid-free Maintenance Immunosuppression in Cardiac Transplantation. International Society for Heart and Lung Transplantation. April 21-24, 2010; Chicago, IL.
77. Petrucci, R, Russell S, Gallagher C, Dordunoo D, Sun B, Yanssens T, Rogers J, Blue L, Jafar M, Frazier OH, Farrar D, and Slaughter MS. Neurocognitive evaluation of destination therapy patients receiving continuous flow left ventricular assist devices. International Society for Heart and Lung Transplantation. April 21-24, 2010; Chicago, IL.
78. Park, SJ., Naftel, DC, Slaughter, MS, Sobieski, MA, Staley, LL, Tallaj, JA, Baldwin, T, Kirklin, JK.
Reducing Adverse Neurological Events in LVAD Patients: Pulsatile vs. Continuous flow? International Society for Heart and Lung Transplantation. April 21-24, 2010; Chicago, IL.
79. Aranda JM, Rogers JG, Aronson KD, Boyle AJ, Russell SD, Edwards B, Zucker MJ, Klodell CT, Sundareswaran KS, Farrar DJ, Slaughter, MS. Quality of Life Improvements are Greater in Destination Therapy than Bridge to Transplant Patients with a Continuous Flow Left Ventricular Assist Device. ACC.10 Meeting, Atlanta, GA. October 2, 2009.
Mark S. Slaughter, M.D. November 15, 2016
64
80. Pantalos G, Ayers C, Rhode S, Haus R, Dowling R, Aggarwal S, Slaughter M. A New Method for Fixation and Stabilization of a Clinical Ventricular Assist Device Percutaneous Lead Heart Failure Society of America. September 13-16, 2009, Boston, MA.
81. Slaughter MS, Ising MS, Tamez D, O'Driscoll G,Voskoboynikov N, Bartoli CR, et al. Reappearance of a Normal Circadian Rhythm after Ventricular Assist Device Implantation Heart Failure Society of America. September 13-16, 2009, Boston, MA.
82. Starling RC, Slaughter MS. Postoperative Heparin Is Not Required in Transitioning Patients with
HeartMate II LVAD to Long Term Warfarin Therapy ISHLT 29th Annual Meeting and Scientific Sessions. April 23, 2009. Paris, France.
83. Bhat G, Slaughter MS. Right Failure after HeartMate II Left Ventricular Assist Device Implantation ISHLT 29th Annual Meeting and Scientific Sessions. April 22-25, 2009. Paris, France.
84. Kimovec M, Boarden W, Slaughter M, Sobieski M, Grutsch R. Anethesia for Patients with Continuous Flow Ventricular Assist Devices for Non-Cardiac Surgery.American Society of Anesthesiologists. Orlando, FL. October, 2008.
85. Pisano C, Nutter A, Perino B, Ziebarth C, Cooke G, Slaughter MS, Silver M. Can We Detect Fatal Heart Failure? HFSA 12th Annual Scientific Meeting. September 21-24, 2008. Toronto, ON, Canada. (Accepted for Presentation.)
86. Slaughter MS, Sobieski MA, Giridharan GA, Pantalos GM, Dowling RD, Prabhu SD, Farrar DJ, Koenig
SC. Intraoperative Evaluation of the Heartmate II Flow Estimator. ASAIO 54th Annual Conference. June 21, 2008. San Francisco, CA (Accepted for Moderated Poster Session.)
87. Slaughter M, Coyle L, Gallagher C, Kurien S, Sobieski M. Destination Therapy: Long Term Outcomes
in Patients with BMI Greater Than 30. ASAIO 54th Annual Conference. June 21, 2008. San Francisco, CA (Accepted for Moderated Poster Session.)
88. Spence PA, Giridharan GA, Wilson G, Dowling RD, Slaughter MS, Sobieski MA, Koenig SC. Acute Hemodynamic Efficacy of a 32-ml Counterpulsation Device During Pharmacologically Induced Hypotension, Hypertension and Heart Failure in Calves. ASAIO 54th Annual Conference. June 20, 2008. San Francisco, CA (Accepted for Slide Session Presentation.)
89. Slaughter M, Sobieski M, Martin M, Kurien S, Coyle L, Graham J, Horrell T, Pederson B. Evaluation of Acoustic Signatures for Hemodynamic Management of Flow Rates in the Heartmate II Flow Estimator. ASAIO 54th Annual Conference. June 20, 2008. San Francisco, CA (Accepted for Slide Session Presentation.)
90. Slaughter M, Coyle L, Kurien S, Horrell T, Graham J, Sobieski M. HeartMate XVE Device End-Of-Life: Results of XVE to HMII Device Exchange. ASAIO 54th Annual Conference. June 20, 2008. San Francisco, CA (Accepted for Slide Session Presentation.)
91. Slaughter M, Sobieski M, Graham J, Horrell T, Pederson B. Evaluation of New Technology: To Reduce
Platelet Adhesion and Coverage of Pyrolitic Carbon Surfaces. ASAIO 54th Annual Conference. June 19, 2008. San Francisco, CA (Accepted for Slide Session Presentation.)
Mark S. Slaughter, M.D. November 15, 2016
65
92. Giridharan GA, Slaughter MS, Sobieski MA, Dowling RD, Aggarwal S, Prabhu SD, Pantalos GM, Farrar
D, Koenig SC. LVAD Support Increases Transvalvular Pressure Gradient. ASAIO 54th Annual Conference. June 19, 2008. San Francisco, CA (Accepted for Slide Session Presentation)
93. Goldstein D, Naka Y, Icenogle T, Slaughter M, Pagani F, Choe J Rose E, Desvigne-Nickens P, Parides M, Rawiel U, Guerchicoff A, Ascheim D, Moskowitz A, Gelijns A, Schmidt AM. The Epidemiology of Bleeding and Clotting in Pulsatile and Continuous Flow LVAD Patients. ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA (Accepted for Oral Presentation.)
94. Slaughter MS, Sobieski MA, Graham JD, Horrell T, Pappas PS, Tatooles AJ, Rao GH, Stein R, Brindise J. Platelet Activation in Patients Supported by Continuous Flow Left Ventricular Assist Devices. ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA (Accepted for Oral Presentation.)
95. Nutter AL, Slaughter MS, Silver MA. A Decline in the VE/VCO2 Slope from Anaerobic Threshold to
Peak Exercise Predicts Short Term Need for LVAD or Heart Transplant. ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA (Accepted for Oral Presentation.)
96. Khan SN, Feldman CM, Slaughter MS and Silver MA. Preferential Improvement in Exercise Time,
Oxygen Consumption and Ventilatory Response in Patients Supported with Pneumatic versus Electric LVADs. ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA (Accepted for Poster Presentation.)
97. Khan SN, Feldman CM, Slaughter MS and Silver MA. Differential slopes of VE/VC02 at Anaerobic Threshold and Peak Exercise: A Possible Indicator of Myocardial Recovery with LVAD Support. ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA (Accepted for Poster Presentation.)
98. Khan SN, Horrell TJ, Graham JD, Sobieski MA, Silver M and Slaughter MS. Hemocompatibility in Long Term LVAD Support: Continuous vs. Pulsatile Flow. ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA (Accepted for Poster Presentations
99. Boyle AJ, Russell SD, Teuteberg JJ, Moazami N, Moore SA, Slaughter M, Farrar DJ, John R. Low Thromboembolism and Pump Thrombosis Potential of the HeartMate II (HM) LVAD. AHA Scientific Sessions 2007. November 6, 2007. Orlando, FL.
100. Cloe J, Gelijins A, Moskowitz A, Naka Y, Goldstein D, Icenogle T, Slaughter M, Pagani F, Dembitsky W, Rawiel U, Hong K, Parides M, Ascheim D, Schmidt AM. The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation or Implantation of Ventricular Assist Devices. Gordon Research Conference. August 19, 2007. Big Sky, MT.
Mark S. Slaughter, M.D. November 15, 2016
66
101. Slaughter MS, Feldman CM, Silver MA, Sobieski MA, Pappas P and Tatooles A. Low Incidence of Neurologic Events During Long-Term Support with HeartMate XVE. ASAIO 53rd Annual Conference. June 9, 2007. Chicago, IL.
102. Feldman CM, Silver MA, Slaughter MS, Sobieski M and Lonergan-Thomas H. Improvement in
Early Oxygen Uptake Kinetics: A Possible Indicator of a Myocardial Recovery with LVAD Support. ASAIO 53rd Annual Conference. June 9, 2007. Chicago, IL.
103. Slaughter M, Sobieski M, Silver M, Pappas P, Tatooles A. Effect of HeartMate II and
Continuous Flow on the Fibrinolytic System. ASAIO 53rd Annual Conference. June 7, 2007. Chicago, IL.
104. Coyle LA, Martin M, Feldman C, Kurien S, Silver MA and Slaughter MS. Destination Therapy:
Results of National and International Travel ASAIO 53rd Annual Conference. June 7, 2007. Chicago, IL.
105. Koenig SC, Giridharan GA, Ionan C, Pantalos GM, Dowling RD, Prabhu S, Sobieski MA,
Slaughter MS. Comparative Studies Between Human, Bovine, and Porcine Systemic Vascular Input Impedances. ASAIO 53rd Annual Conference. June 7, 2007. Chicago, IL.
106. Koenig SC, Giridharan GA, Ionan C, Pantalos GM, Dowling RD, Prabhu S, Sobieski MA,
Slaughter MS. Systemic Vascular Input Impedance in Humans, Calves, and Pigs: Clinical Implications with Medical Devices and Xenotransplantation. ISHLT 27th Annual Meeting and Scientific Sessions. April 25-28, 2007. San Francisco, CA (Poster Presentation)
107. Slaughter MS, Sobieski MA, Pantalos GM, Giridharan GA, Dowling RD, Prabhu S, Farrar DJ,
Koenig SC. Left Ventricular Pressure Unloading with Continuous and Pulsatile Left Ventricular Assist Devices in Advanced Heart Failure Patients. ISHLT 27th Annual Meeting and Scientific Sessions. April 25-28, 2007. San Francisco, CA (Poster Presentation).
108. Slaughter MS, Sobieski MA, Gallagher C, Dia M, Silver MA. Long-Term Support with
Continuous Flow LVAD’s: Effect of Reduced Pulsatility on Renal Function. ISHLT 27th Annual Meeting and Scientific Sessions. April 25, 2007. San Francisco, CA (Poster Presentation).
109. Lietz K, Long J, Kfoury A, Slaughter M, Silver M, Milano C, Rogers J, Naka Y, Mancini D, Miller
LW. Center Experience and Outcomes of Left-Ventricular Assist Device Implantation as Destination Therapy (DT) – Analysis of Thoratec DT Registry 1998-2005. ACC - American College Cardiology. March 26, 2007. New Orleans, LA.
110. Slaughter MS, Sobieski II MA, Pappas PS, Tatooles AJ. Emergency Insertion of HeartMate XVE
for Persistent Cardiogenic Shock After Acute Myocardial Infarction. ASAIO. June 8, 2006. Chicago, IL.
111. Koenig SC, Dowling RD, Slaughter MS, Sobieski II MA, Giridharan GA, Pantalos GM. Vascular
Pulsatility in Clinical Patients with a Continuous or Pulsatile VAD. ASAIO. June 8, 2006. Chicago, IL.
Mark S. Slaughter, M.D. November 15, 2016
67
112. Slaughter MS, Pederson B, Tatooles AJ, Sobieski II MA. Hydrophone Monitoring: A Novel Method for Non-Invasive Assessment of LVAD Device Failure. ASAIO. June 8, 2006. Chicago, IL.
113. Leitz K, Long J, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers J, Miller LW. The Impact
of Patient Selection on Long-Term Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy for End-Stage Heart Failure. International Society of Heart & Lung Transplantation. April, 2006. Madrid, Spain.
114. Leitz K, Long J, Slaughter MS, Miller L. Preoperative Risk Factors for Early Mortality Following
Use of Left Ventricular Assist Devices as Destination Therapy for End-Stage Heart Failure.American Heart Association. Dallas, TX. November, 2005.
115. Agadi SG, Lonergan-Thomas H, Brennan S, Cianci P, Slaughter MS, Silver MA. Impact of Left
Ventricular Assist Device Destination Therapy on Ventricular Re-Synchronization. Chest 2005 (Poster).
116. Sobieski MA, Kwok WA, Pappas PS, Tatooles AJ, Slaughter MS. Reducing the Effects of the
Systemic Inflammatory Response to Cardiopulmonary Bypass: Can Single Dose Steroids Blunt SIRS? American Society of Extracorporeal Technology. New Orleans, LA. March 5, 2005.
117. Long D, Sobieski II MA, Slaughter MS. Utilization of the HeartMate XVE Left Ventricular Assist
System as Destination Therapy in a Patient with Ischemic Cardiomyopathy: A Case Report. American Society of Extracorporeal Technology. New Orleans, LA. March 5, 2005.
118. Sobieski II MA, Hart D, Pappas PS, Tatooles AJ, Slaughter MS. Utilization of ECMO as a Bridge
to Ventricular Assist and Bridge to Successful Transplantation: A Case Report. American Society of Cardiovascular Perfusion, Tampa, FL. January, 2005.
119. Farrar DJ, Kormos RL, Frazier OH, Long J, Stueber, Slaughter MS, Sun B, Hill JD. Right
Ventricular Afterload in Patients with Continuous Flow and Pulsatile Flow LVADs: Implications for Right Heart Function. International Society of Rotary Blood Pumps. Cleveland, Ohio.
120. Slaughter MS. A Webcast Course on: Advanced Surgical and Clinical Management Strategies
for Patients Requiring Univentricular or Biventricular Support with the Thoratec IVAD. Thoratec Corporation. December 7, 2004.
121. Slaughter MS, Sobieski MA, Silver MA, Tatooles AJ, Pappas PS. Epicardial Blood Flow: A
Comparative Evaluation of the Thoratec PVAD and the HeartMate IP Ventricular Assist Devices. ASAIO. 50(2), 130; Mar-Apr 2004. ASAIO. Washington, DC, June 18, 2004.
122. Slaughter MS, Tsui SL, El-Banayosy A, Kormos RL, Icenogle TB, Hill JD. Home Discharge with a
Thoratec VAD using the TLC-II Portable Driver. ASAIO. 50(2), 120; Mar-Apr 2004. ASAIO. Washington, DC. June 18, 2004.
123. Slaughter MS, Tsui S, El-Banayosy A, Kormos RL, Icenogle TB, Hill JD. The Thoratec IVAD: A
New Implantable Ventricular Assist Device. ISHLT. San Francisco, CA. April 21-24, 2004. (Poster).
Mark S. Slaughter, M.D. November 15, 2016
68
124. Sobieski II MA, Slaughter MS, Hart D, Pappas PS, Tatooles AJ. Prospective Study on Prime
Reduction via the Cardioplegia Delivery System and the Effects on Blood Product and Hemoconcentrator Usage Intra-operatively. American Academy of Cardiovascular Perfusion. San Antonio, TX. January 24, 2004.
125. Evans CC, Walker LA, Rundell VL, George TA, Pappas PS, de Tombe P, Slaughter MS.
Mechanical Support Normalizes Cardiac Myofilament Force-ATPase Relationship in Heart Failure. American Heart Association. Orlando, FL. November 9-12, 2003.
126. Tatooles AJ, Pappas PS, Gordon PJ, Slaughter MS. Robotic Mitral Valve Repair: Improved
Results and Patient Satisfaction. 3rd World Congress on Heart Disease- New trends in Research, Diagnosis and Treatment. July 12-15, 2003.
127. Sobieski M, George T, Slaughter MS. Initial Experience using the Thoratec Mobile Computer in
Conjunction with the TLC-II Ventricular Assist Device Driver. ASAIO. Washington, DC. June 19, 2003.
128. Slaughter MS, Sobieski M, Pappas PS, Tatooles AJ. Hemodynamic advantage of limited stroke
volume vs rate reduction. ASAIO. Washington, DC. June 19, 2003. 129. Banbury MK, Kouchoukos NT, Allen KB, Slaughter MS, Berry G, Horvath KA. The Histologic
Characteristics of Captured Particulate Emboli Using the Embol-X Intra-Aortic Filter during Cardiopulmonary Bypass. Outcomes: The Key West Meeting. Key West, FL. May 21-24, 2003.
130. Sobieski II MA, George TA, Slaughter MS. Initial Experience using the Thoratec Mobile
Computer in Conjunction with the TLC-II Ventricular Assist Device Driver. ASAIO, 49(2), 169; Mar-Apr, 2003.
131. Slaughter MS, Sobieski II MA, Pappas PS, Tatooles AJ. Weaning the Thoratec LVAD:
Hemodynamic Advantage of Limited Stroke Volume vs. Rate Reduction. ASAIO, 49(2),168; Mar-Apr, 2003.
132. Silver MA, Slaughter MS, Pappas PS, Tatooles AJ, Szabo S. Long-Term Survival Following Left
Ventricular Assist and Comprehensive Medical Management As Bridge to Recovery Therapy for Advanced Heart Failure. ISHLT, 22(1S): S211, 2003.
133. Tsui S, Slaughter MS, Hill J, Burton N, Korfer R. Initial Human Experience with the Thoratec
IVAD: A Versatile Implantable Uni- or Bi-ventricular Assist Device. 134. Kumar A, Ozinga D, Boarden W, Slaughter MS. O.R. Extubation after DaVinci Robotic Mitral
Valve Repair. Society of Cardiovascular Anesthesiologists. Aspen, CO. March, 2003. (Poster) 135. Sobieski M, Hart D, Pappas PS, Slaughter MS. Cardiopulmonary Bypass Circuit with Modified
Assisted Venous Drainage in Conjunction with Robotic Mitral Valve Repair. AACP. San Diego, CA. February, 2003.
Mark S. Slaughter, M.D. November 15, 2016
69
136. Silver MA, Slaughter MS, Pappas PS, Tatooles AJ, Szabo S. Long-Term Survival Following Left Ventricular Assist and Comprehensive Medical Management as Bridge to Recovery Therapy for Advanced Heart Failure. ISHLT. Vienna, Austria, 22(1S): S211. 2003.
137. Tsui S, Slaughter MS, Hill J, Burton N, Korfer R. Initial Human Experience with the Thoratec
IVAD: A Versatile Implantable Uni- or Bi-ventricular Assist Device. ISHLT. Vienna, Austria, 22(1S): S201. 2003.
138. Sobieski II MA, Hart D, Pappas PS, Slaughter MS. Cardiopulmonary Bypass Circuit with
Modified Assisted Venous Drainage in Conjunction with Robotic Mitral Valve Repair. AACP. San Diego, CA. January, 2003. JAACP; 24: 49.
139. Banbury MK, Kouchoukos NT, Horvath KA, Slaughter MS, Weissan N, Berry G. The Embol-x
Intra-aortic Filter Reduces Morbidity In Cardiac Surgery: A Multi-centered Randomized Trial of 1,289 Patients. STS. San Diego, CA. January, 2003.
140. Pappas PS, Tatooles AJ, Slaughter MS. Da Vinci Robotic Mitral Valve Repair: Outpatient
Procedure? STS. San Diego, CA. January, 2003. 141. Pappas PS, Tatooles AJ, Slaughter MS. Robotic Mitral Valve Repair: Home Discharge Less than
24 Hours Postoperatively. ATS. January, 2003. 142. Slaughter MS, Pappas P, Tatooles AJ. Skinned Myocyte Contractile Function in Patients with LV
Dysfunction: Predictor of Myocardial Recovery. 8th World Congress on Heart Failure- Mechanisms and Management. Washington, DC. July, 2002.
143. Slaughter MS. Skinned Myocyte Contractile Function in Patients with LV Dysfunction:
Predictor of Myocardial Recovery? The Journal of Heart Failure 7(1): 44, July 2002. 144. Evans CC, de Tombe P, George T, Pappas P, Slaughter MS. Force-ATPase Relationship in
Myofilaments from Patients with Heart Failure and Mitral Valve Disease. ISHR. Madison, WI. July, 2002.
145. Slaughter MS, Silver M, Pappas P, Tatooles A. Home Discharge Experience with the Thoratec
LVAD TLC-II Portable Driver. ASAIO. New York, NY. June, 2002. 146. Slaughter MS, Evans C, Pappas P, Tatooles A. Skinned Myocyte Function and ATP Use in
Patients with LV Dysfunction: Predictor of Recovery? ASAIO. New York, NY. June, 2002. 147. Slaughter MS, Pappas P, Silver M, Tatooles A. Neurologic and Bleeding Complications
Associated with Thoratec Ventricular Assist Device. ASAIO. New York, NY. June, 2002. 148. Mussivand T, Harasaki H, Litwak K, Slaughter MS, et al. In Vivo Evaluation of the
Biocompatibility of a Totally Implantable VAD (HeartSaver VAD). ASAIO. New York, NY. June, 2002.
149. Slaughter M, Pappas P, Tatooles A. First U.S. Home Discharge with the Thoratec TLC-II
Portable VAD Driver. Advances in Cardiac Surgery. San Diego, CA. 2001.
Mark S. Slaughter, M.D. November 15, 2016
70
150. Slaughter MS, George T, Sobieski M, Tatooles A, Pappas P. Home Discharge with the Thoratec
TLC-II Portable Driver. 6th Symposium WAITS. Ottawa, CA. Aug. 18, 2001. 151. Slaughter MS, George T, Sobieski M, Tatooles A, Pappas P. Home Discharge with the Thoratec
TLC-II Portable Driver. Cardiovascular Engineering. 152. Slaughter MS, George T, Sobieski M, Silver M. Initial Experience with Outpatient Excursions
Using the Thoratec TLC-II Portable Driver. Cardiovascular Engineering. 153. Slaughter MS, George T, Sobieski M, Silver M. Initial Experience with Outpatient Excursions
Using the Thoratec TLC-II Portable Driver. 6th Symposium WAITS. Ottawa, CA. Aug. 19, 2001. 154. Slaughter MS, Pappas PS, Tatooles AT. Preliminary Experience with a New Synthetic Coronary
Artery Bypass Graft. (ARIA). 4th Annual New Era Cardiac Care. 84, 2001. (Abstract) (ARIA). New Era in Cardiac Care. Laguna Niguel, CA. January, 2001.
155. Akrami BA, Silver MA, Earhart B, Slaughter MS. Improved and sustained early exercise oxygen
kinetics with mitral valve repair and LVAD support accounts for improved functional status. Journal of Cardiac Failure. 6 (3) Suppl. 2: 38, 2000.
156. Silver MA, Cianci P, Longergan-Thomas H, George TA, Szabo S, Slaughter MS. Rapid up-
titration of beta-blocker therapy in patients being supported with a left ventricular assist device. Journal of Cardiac Failure. 6 (3): 39, 2000.
157. Silver MA, Slaughter MS, Pappas PS, Tatooles AJ, Szabo S. Short-term results of left ventricular
assist and comprehensive medical management as bridge to recovery therapy for advanced heart failure. JACC 2000; 35: 229A.
158. Slaughter MS, Silver M, Tatooles A, Pappas P. Early results of planned bridge to recovery using
Thoratec left ventricular assist device in severe idiopathic dilated cardiomyopathy. ASAIO J 46(2): 186. New York, NY. June, 2000.
159. Silver MA, Slaughter MS, Pappas PS, Tatooles AJ, Szabo S. Short-term results of left ventricular
assist and comprehensive medical management as Bridge to recovery therapy for advance heart failure. American College of Cardiology. Dallas, TX. March, 2000.
160. Slaughter MS, Tatooles A, Hodakowski G, Pappas P. The effect of the internal thoracic artery
on intermediate survival in dialysis patients undergoing coronary revascularization. Chest Supplement 1999. (Abstract) American College of Chest Physicians. Chicago, IL. October, 1999. (Poster).
161. Silver M, Lazzara D, Slaughter MS, Szabo S, Pappas P. Thoracic bioimpedence accurately
determines cardiac output in patients with left ventricular assist devices. Journal of Cardiac Failure 5(3): 38, 1999.
Mark S. Slaughter, M.D. November 15, 2016
71
162. Silver M, Slaughter M. Short-term results of left ventricular assist and comprehensive heart failure management as bridge to recovery therapy for advanced heart failure. Heart Failure Summit V. Cleveland, OH. October, 1999.
163. Silver M, Lazzara D, Slaughter M, Szabo S, Pappas P. Thoracic bioimpedence accurately
determines cardiac output in patients with left ventricular assist devices. Heart Failure Society of America. San Francisco, CA. September, 1999.
164. Slaughter MS, Silver M, Hodakowski G, Pappas P. Mitral valve annuloplasty for ischemic mitral
regurgitation and severe ventricular dysfunction. Journal of Cardiac Failure 5(3):35, 1999. 165. Slaughter M, Silver M, Hodakowski G, Pappas P. Mitral valve annuloplasty for ischemic mitral
regurgitation and severe ventricular dysfunction. Heart Failure Society of America. San Francisco, CA. September, 1999.
166. Tatooles A, Pappas P, Guillory J, Faraci P, Hodakowski G, Perelman M, Slaughter MS. Coronary
artery bypass grafting in patients with renal failure on chronic dialysis. Naurice M. Nesset Research Forum Proceedings, Vol 1, 1997.
167. Slaughter MS, Pappas P, Evans D, Tatooles A, Hodakowski G. Operating room extubation in adults requiring coronary artery bypass grafting. Chest Supplement
112(3):1285, 1997. 168. Slaughter M, Pappas P, Evans D, Tatooles A, Hodakowski G. Operating room extubation in
adults requiring coronary artery bypass grafting. American College of Chest Physicians. New Orleans, LA. October, 1997. (Poster).
169. Slaughter MS, Kshettry V, Smith P, Foker J: Internal mammary artery for arterial pressure
monitoring after pediatric surgery. Clinical Digest Series: Pediatrics Digest, 1994.
170. Smith P, Slaughter M, Petty M, Shumway S, Kshettry V, Bolman III RM. Abdominal complications following lung transplantation. ISHLT. Venice, Italy. March, 1994.
171. Slaughter MS, Nielsen K, Bolman III RM. Heparin-coated circuits as treatment for bleeding
while on extracorporeal membrane oxygenation. Pathophysiology and Techniques of Cardiopulmonary Bypass: Cardiothoracic Surgery Symposium. San Diego, CA. February, 1994.
172. Slaughter M, Braulin E, Bolman III RM, Moline E, Shumway S. Pediatric Cardiac
Transplantation: Results of two and five year follow-up. First International Congress on Pediatric Transplantation. Minneapolis, MN. Aug., 1993.
173. Slaughter M, Nielsen K, Bolman III RM. Extracorporeal membrane oxygenation (EMCO) after
lung or heart-lung transplantation. ASAIO. New Orleans, LA. April, 1993. 174. Pearce W, Slaughter M, Salyapongse N, LeMaire S, Yao J, McCarthy W. Aortic diameters as a
function of age, gender and body surface area. Central Surgical Association. Cincinnati, OH. March, 1993.
Mark S. Slaughter, M.D. November 15, 2016
72
175. Slaughter M, Olson M, Lee J, Ward H. A fifteen-year continuous would surveillance study in patients following coronary artery bypass. Society of Thoracic Surgeons. San Antonio, TX. January, 1993. (Poster).
Thoracic Residency Program:
ACGME 2011-Present
Thoracic Residency Program
University of Louisville 40202
Thoracic Residency Program 2011
Re-accreditation
Rewrote PIF for Thoracic Residency 2009
Thoracic Residents
1) Adam Protos, MD 2015-2016
STS Advocacy Scholarship 2016
ACS Leadership and Advocacy Summit
2) Adam Ubert, MD 2014-2016
3) John Chaney, MD 2013-2015
1st Place Winner 2013-2014
JCTSE and TSDA CT Surgery Resident Top Gun Competition
Award
2nd Place AATS Resident Poster Competition 2015
4) James Neel, MD 2012-2014
JCTSE and TSDA CT Surgery Resident Top Gun Competition 2013
VAD/Transplant Super Fellows:
1) Michele Gallo, MD 2016-2017
Padua, Italy
Mark S. Slaughter, M.D. November 15, 2016
73
2) Anna Meyer, MD 2010-2011
Hanover, Germany
Visiting Faculty:
Jennifer Conway
Toronto Sick Kids VAD Management 2012
ISHLT Travel Award 2012
Research Residents:
Dr. Erin Schumer 2013-2016
Hanover, Germany
ISHLT Travel Award
2nd place AATS Resident Poster Competition 2014
WTS Scholarship Program 2015
ISHLT Travel Grant Award
Micah Whited, MD 2016-2017
Matt Black, MD 2015-2016
Paul Linsky, MD 2012-2013
Matt Fox, MD 2009-2010
Medical Students:
Paul Henly
Distinction in Research 2016-2017
Michael Rogers 2015
STS Looking to the Future Scholarship
Distinction in Research
Mickey Ising 2014
AMA Physicians of Tomorrow Award
STSA James W. Brooks Medical Student Scholarship 2014
Daniel Kütting MD
Student from Germany 2013
Carlo Bartoli, MD, PhD student 2009-2011
STSA James W. Brooks Medical Student Scholarship 2011
Master’s Degree in Bioengineering/Mentor:
Mitchell J. Buller, B.S 2013
Master’s Thesis Advisor/Mentor
Mark S. Slaughter, M.D. November 15, 2016
74
Keith Zoeller 2012-2014
Master's Thesis Advisor/Mentor
Mickey Ising 2010-2011
Master’s Thesis Advisor/Mentor
Joel Graham 2009-2010
Master’s Thesis Advisor/Mentor
Bioengineering Co-op Students:
Young Choi 2012-2016
Whitaker International Fellowship Grant Recipient 2016/2017
Tim Horrell 2008
Joel Graham 2008 -2009
Mickey Ising 2010
Summer Research Associates:
Paul Henley 2016
(Medical Student University of Louisville) AATS Student for the day award
Kevin Luftman 2010
(Medical Student University of Louisville)
Sam Schwartz (Northwestern University) 2011
(Bioengineering student Northwestern University)
Community Service:
Metro United Way Volunteer 2011 - present
Leadership/Management Development:
Professional Training: Team Building Workshop, ARISE Executive Coaching
Department of Cardiovascular and Thoracic Surgery Faculty Retreat 2016
Academic Leadership Program: Human Resources Panel: 2015
“Working with HR to Recruit, Retain, & Recognize Faculty and Staff”
CHI Quarterly Senior Leadership Team Meeting 2014
Mark S. Slaughter, M.D. November 15, 2016
75
Strategic Thinking, Carnegie Mellon
Denver, Colorado
CHI Medical Director Summit:
August 2013
Leading Change, Influencing Others, and Using Data to Lead Effectively
Denver, Colorado
AAMC Executive Development Seminar for Associate Deans
and Department Chairs
Fulfilling Leadership and Management Roles Tempe, Arizona 2014
